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 ABSTRACT 
 
The primary aim of this study was to determine if various typologies of 
psychiatric diagnoses and patterns of comorbidity are differentially related to the medical 
lethality of adolescent suicide attempts.  The secondary aim was to determine if the 
relationship between psychopathological comorbidity and suicide attempt lethality is 
significantly different across gender, age, and race in adolescents.  To investigate these 
relationships, psychiatric evaluations were reviewed for all adolescents that presented to 
Children’s Hospital Boston (CHB) from 2006 to 2010 for a suicide attempt (N = 375).  
Bivariate and OLS regression analyses were used to test hypotheses.  Bivariate results 
showed that attempters diagnosed with a Substance Abuse Disorder comorbid with any 
other disorder had higher levels of suicide attempt lethality than those without the 
diagnosis.  Additionally, having Bipolar or Mood Disorder NOS in combination with 
either Substance Abuse alone or Substance Abuse and Disruptive Disorders had a 
significant positive relationship with suicide attempt lethality when compared to other 
comorbidity patterns.  In OLS regression, having Substance Abuse comorbid with any 
other disorder was the only significant diagnostic predictor of lethality.  Female gender 
did not have a significant relationship with lethality.  Age group was not predictive of 
lethality in regression analysis.  African-American/Black race had a negative relationship 
with lethality in bivariate and multivariate analyses.  Study findings have important 
implications for practice, policy, and future research with suicidal adolescents.  Results 
suggest that improvements in the assessment and treatment of substance abuse in suicidal 
adolescents can play a critical role in decreasing the adolescent suicide rate.  Screening 
 for symptoms other than depression, such as substance use, will be critical to effective 
suicide prevention practices.  Future research should focus on the development of 
effective treatment strategies with suicidal adolescent substance abusers, and aim for a 
better understanding of suicidal behaviors of adolescents with comorbid bipolar and 
substance abuse diagnoses.  In order to further develop prevention and treatment 
strategies with this population, policies must be initiated that will support their 
advancement.
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CHAPTER I 
 
Purpose and Specific Aims 
 Suicide is the third leading cause of death for adolescents, as compared to the 
eleventh leading cause of death for all ages (CDC, 2008).  Suicide attempts by 
adolescents occur at a disturbing rate, as 7% of high school students report having 
attempted suicide one or more times, with 2% of students reporting an attempt that 
required medical treatment (CDC, 2008).  The set of risk factors for adolescent suicide is 
complex and not fully understood.  However, research suggests that medical lethality of a 
suicidal act, defined as the seriousness of the physical consequences or risk to life, is the 
main determinant of the likelihood of death following a suicide attempt (Nasser & 
Overholser, 1999).  Further, it has been suggested that the characteristics of highly lethal 
suicide attempters may be similar to those of suicide completers (Beautrais, 2003; Brent, 
1987).  Therefore, studies differentiating the medical lethality of attempts can help to 
expand the knowledge base about risk factors for adolescent suicide. 
Psychopathology is one risk factor for adolescent suicide that is not 
comprehensively understood.  Previous research suggests mood disorders such as 
depression are common diagnoses in adolescents that both attempt and complete suicide.  
Additionally, we know that psychopathological comorbidity, defined as the co-
occurrence of two or more psychiatric diagnoses, increases the risk for suicide in 
adolescents (Wagner, 2009).  However, it is unclear at this time if certain combinations 
of psychiatric disorders or particular comorbidity patterns pose more of a threat to the 
medical lethality of suicide attempts in this population.  The goal of this study is to 
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determine if there is a relationship between psychopathological comorbidity and the 
medical lethality of suicide attempts in adolescents, and to better understand the nature of 
this relationship.  The findings will enhance our understanding of the specific 
psychopathological and demographic risk factors that predict the medical seriousness of 
adolescent suicide attempts.  Because the existing literature on the relationships between 
these constructs is largely outdated, the overarching goal of this study is to examine these 
associations in the current context in an effort to update the knowledge base in the field. 
The primary aim of this study is to determine if various typologies of psychiatric 
diagnoses and patterns of comorbidity are differentially related to the medical lethality of 
adolescent suicide attempts.  The secondary aim is to determine if the relationship 
between psychopathological comorbidity and suicide attempt lethality is significantly 
different across gender, age, and race in the adolescent population. 
 
Theory and Previous Studies 
Suicide Attempts in Adolescence 
Examining adolescent suicide attempts through a developmental lens is critical.  
There are significant cognitive shifts as well as physiological and socio-emotional 
changes that put adolescents at risk for suicidal behaviors.  Adolescent and adult suicide 
attempts have different characteristics.  For instance, adolescents attempt suicide with 
greater frequency (Safer, 2007) while adult suicide attempters are more likely to have 
deadly intentions (Parellada et al., 2007).  Adolescence represents a period of rapid 
reorganizations in all developmental domains (Lerner, Lerner, von Eye, Ostrom, Nitz, 
Talwar-Soni, et al., 1996).  The influence of these developmental changes is essential to 
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our knowledge of risk factors, and makes the understanding of adolescent suicide 
attempts distinctly different from those of adults, creating a need to examine the 
populations separately. 
Much of the distinction between adolescent and adult suicide attempts can be 
attributed to cognitive differences in decision-making processes in their respective life 
stages.  Piaget’s (1972) cognitive developmental stage model places adolescents in the 
formal operations stage, where they begin to perform more complex mental processes 
and start using more systematic approaches to reasoning.  The cognitive processes 
associated with goal-directed behavior also continue to develop throughout adolescence 
(Keating & Bobbitt, 1978), suggesting that not all adolescents who engage in suicidal 
behaviors have fully developed conceptualizations about suicide.  Because of their lack 
of experience and limitations to problem-solving in this stage, adolescents often resort to 
using ineffective and unhealthy coping skills that involve risky and self-destructive 
behaviors (Baumeister, 1990).  Elkind (1967) suggests specifically that the early to mid-
adolescent period is characterized by a self-absorbed, egocentric focus on one’s own 
mental processes.  From this we can posit that younger adolescents may be even more 
vulnerable to using more detrimental coping mechanisms, such as lethal suicide attempts, 
than their older adolescent counterparts. 
To better understand risk factors for adolescent suicide, it important to examine 
potential disparities in cognitive maturity within the adolescent period itself.  Some 
studies indicate that changes in cognitive capacity after mid-adolescence are very modest 
in magnitude (Steinberg, 2008).  Conklin, Luciana, Hooper, and Yarger (2007) found 
performance on tasks that activate the frontal lobes to improve through middle 
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adolescence, until about age sixteen.  Other research indicates that important advances 
are made at some time in late adolescence, and these changes have a profound effect on 
the ability to make mature decisions on a consistent basis (Halpern-Felsher & Cauffman, 
2001).  The development of the executive functioning of the frontal lobes is critical to the 
ability to recognize the consequences of one’s actions.  Adolescence marks a period of 
heightened risk-taking, and increases in risky behaviors are closely linked to the 
physiological changes found in the onset of puberty.  Early to mid-adolescence represents 
a time where adolescents are more prone to acting on biologically and emotionally driven 
motivations because they do not have the cognitive capacity to cope and reason with 
them (Steinberg et al., 2006). 
In addition to the cognitive and physiological changes experienced during 
puberty, adolescents also experience changes in socio-emotional development during this 
stage that may precipitate suicidal behaviors.  The psychosocial process of identity 
development first emerges during adolescence (Erikson, 1968).  Peers, interpersonal 
relationships, and school-based achievement become of paramount importance to 
adolescents (Wagner, 2009), and failures in these areas can lead to a significant amount 
of distress.  Acute stress in these areas can contribute to an overall feeling of 
disconnectedness for adolescents, which heightens their vulnerability to suicidal thoughts 
and behaviors (Wagner, 2009).  From this we can posit that it may be more difficult for 
adolescents than adults with a psychopathological disturbance to find solutions other than 
suicide to cope with distress. 
Further complicating the understanding of the role of development in suicidal 
behavior of adolescents is that the physiological and socio-emotional developmental 
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trajectory is experienced very differently across gender.  Pubertal development typically 
occurs two years earlier for females than males.  Females with an earlier onset of puberty 
tend to experience more significant distress than those with a later onset (Dubas & 
Petersen, 1993; Ge, Conger, & Elder, 2001).  Conversely, males with late pubertal onset 
tend to experience greater challenges than their peers (Graber, Lewinsohn, Seeley, & 
Brooks-Gunn, 1997).  There may be specific developmental periods during which males 
and females are particularly vulnerable to suicide attempts.  Boeninger, Masyn, Feldman, 
and Conger (2010) found the prevalence patterns of suicide attempts to be similar for 
males and females, with both increasing through middle adolescence and then declining.  
However, they found the risk for female suicide attempts to decline slightly more rapidly 
after this mid-adolescence period. 
Suicide Attempt Lethality 
 O’Carroll and colleagues (1996) define a suicide attempt as a “potentially self-
injurious behavior with a non-fatal outcome, for which there is evidence (either implicit 
or explicit) that the person intended at some (nonzero) level to kill him/herself” (247).  
Despite this seemingly specific nomenclature, the suicide attempt definition is frequently 
disputed by mental health professionals (Wagner, Wong, & Jobes, 2002), and research 
studies on suicide attempts have used a variety of definitions over the years (Wagner, 
2009).  This is problematic as there are vastly different lethality levels inherent in the 
suicide attempt construct (Wagner et al., 2002) which demonstrates the importance of 
using instruments with strong psychometric properties in adolescent suicide attempt 
research. 
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One component of self-harm behavior that is critical to the determination of 
suicide risk and should be measured in studies on suicide attempts is medical lethality.  
Nasser and Overholser (1999) define the medical lethality of a suicide attempt as the 
“seriousness of the physical consequences or risk to life” (423).  The concept of medical 
lethality is important in suicide research, as individuals who make highly lethal suicide 
attempts have been found to exhibit a similar risk profile to suicide completers 
(Beautrais, 2003; Brent, 1987).  Lethality is especially important to examine in suicide 
research with adolescents, as they are significantly less certain of the possible fatal 
outcome of their suicide attempt than adults (Parellada et al., 2007).  This suggests that 
adolescents do not have the same knowledge of lethality of different suicide attempt 
methods (Nasser & Overholser, 1999) and that there may be characteristics other than 
depression severity and suicidal intent that contribute to adolescent suicide attempt 
lethality.  
In a study on adolescent and young adult suicide attempts, Swahn and Potter 
(2001) found young age (13-17 years) to be significantly associated with a nearly lethal 
suicide attempt.  Despite this knowledge, few research studies have examined factors 
associated with the medical lethality of adolescent suicide attempts specifically 
(Beautrais, 2003; Brent, 1987; Nasser & Overholser, 1999) and no studies have been 
conducted on this topic in the past 10 years.  Because of the scarcity of research in this 
area, it is still unclear what factors are associated with suicide attempts of high lethality 
(Swahn & Potter, 2001), and even less knowledge exists specific to the adolescent suicide 
attempter population. 
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Lethality and Psychopathological Comorbidity 
Psychiatric disorders are the most common risk factor for suicide attempts among 
adolescents (Brent, 1995).  The issue of psychopathological comorbidity, defined as the 
co-occurrence of two or more psychiatric disorders, has garnered attention from 
adolescent suicide researchers because certain combinations of disorders have been found 
to increase the risk of suicidal behavior (Wagner, 2009).  There is still some controversy 
regarding which types of psychopathology are more significant risk factors for suicide in 
the adolescent population, although it has been suggested that a diagnosis of a mood 
disorder with comorbidity appears to increase the risk of suicide (Nasser & Overholser, 
1999; Renaud, Berlim, McGirr, Tousignant, & Turecki, 2008).  However, the literature 
still remains unclear about what specific patterns of comorbidity contribute to increased 
suicide risk among youth (Fordwood, Asarnow, Huizar, & Reise, 2007).  In order to 
better understand the role of psychopathological comorbidity as a risk factor for 
adolescent suicide, the impact of specific typologies of psychiatric diagnoses on the 
lethality of adolescent suicide attempts must be further examined.  Table 1 summarizes 
the findings and limitations of related studies. 
Table 1 
Findings and Limitations of Studies on Psychopathology and Suicide Attempts in 
Adolescents 
Study Sample Findings Limitations 
Beautrais 
(2003) 
Child, adolescent, 
and young adult 
suicide completers 
Males, because of use of 
more lethal method, were 
more likely to complete 
Not a purely 
pediatric sample; 
suicide attempts of 
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(N = 60), serious 
suicide attempters 
(N = 125), and non-
suicidal/non-
attempter 
comparisons (N = 
151) 
suicide.  Suicide 
completers more likely 
than attempters to have 
bipolar disorder.  Suicide 
attempters more likely than 
completers to have mood 
disorders.  Suicide 
attempters more likely than 
non-attempters to have 
mood, antisocial, 
substance use, or anxiety 
disorders. 
moderate and low 
lethality of attempt 
not differentiated; 
effect of 
comorbidity not 
assessed. 
Brent (1987) Youth suicide 
attempters (N = 
131) 
Comorbid mood and 
substance abuse disorders 
were predictive of suicide 
attempts of higher 
lethality. 
Study conducted 20 
years ago; exact age 
of subjects unclear; 
disruptive disorders 
not measured. 
Fordwood, 
Asarnow, 
Huizar, & 
Reise (2007) 
Depressed 
adolescent primary 
care suicide 
attempters (N = 
451) 
Comorbid externalizing 
behaviors was strongest 
unique predictor of suicide 
attempts after accounting 
for severity of depressive 
symptoms. 
Not a purely 
pediatric sample; 
lethality of attempt 
not differentiated. 
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Kelly, 
Cornelius, & 
Lynch (2002) 
Adolescent 
psychiatrically 
disordered suicide 
attempters (N = 96) 
and psychiatrically 
disordered non-
attempters (N = 96) 
Bipolar, inhalant use, 
cocaine use, and 
hallucinogen use disorders 
were predictive of 
attempted suicide after 
adjusting for all other 
covariates. 
Lethality of attempt 
not differentiated. 
Kelly, Lynch, 
Donovan, & 
Clark (2001) 
Adolescent 
psychiatrically 
disordered suicide 
attempters (N = 89) 
and psychiatrically 
disordered non-
attempters (N = 
343) 
Major depression 
predictive of suicide 
attempts.  Females with 
comorbid alcohol and 
conduct disorders 3 times 
more likely to have 
attempted suicide. 
Lethality of attempt 
not differentiated. 
Nasser & 
Overholser 
(1999) 
Adolescents with 
suicide attempts of 
low (N = 20), 
medium (N = 20), 
and high (N = 20) 
lethality 
Adolescents with 
comorbid depression and 
attention deficit disorder 
more likely to make 
suicide attempts of high 
lethality.  Lethality groups 
did not differ in diagnoses 
of depressive, adjustment, 
Study conducted 
over 10 years ago; 
only utilized 
bivariate analyses; 
sample size of 
lethality groups too 
small to conduct 
regression analyses. 
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substance abuse, or bipolar 
disorders. 
Nrugham, 
Larsson, & 
Sund (2008) 
Adolescent suicide 
attempters (N = 36) 
and non-attempters 
(N = 229) 
Depressive disorder 
predicts suicidal acts for 
older adolescents only. 
Relatively small 
sample size; loose 
definition of suicide 
attempt; comorbidity 
not assessed; 
lethality of attempt 
not differentiated. 
Portzky, 
Audenaert, & 
van Heeringen 
(2005) 
Adolescent suicide 
completers (N = 19) 
All 19 had a psychiatric 
disorder; 13 had a mood 
disorder.  In 9 cases, 
comorbid mood and 
substance abuse disorder. 
Autopsy method; 
small sample size; 
no attempt or control 
groups. 
Renaud, 
Berlim, 
McGirr, 
Tousignant, & 
Turecki (2008) 
Children and 
adolescents who 
committed suicide 
(N = 55) and 
community controls 
(N = 55) 
Depressive, substance 
abuse, and disruptive 
disorders predict suicide.  
Of suicide completers, 
60% had comorbid 
disorders, compared to 
9.1% of controls. 
Autopsy method; 
relatively small 
sample size; did not 
specify comorbidity 
patterns; no attempt 
groups. 
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Swahn & 
Potter (2001) 
Adolescent nearly 
lethal (N = 37) and 
less lethal (N = 3) 
and young adult 
nearly lethal (N = 
116) and less lethal 
(N = 44) suicide 
attempters 
Young age (13-17 years) 
significantly associated 
with nearly lethal suicide 
attempts. 
Psychopathology 
and comorbidity not 
assessed. 
Wu, Hoven, 
Liu, Cohen, 
Fuller, & 
Shaffer (2004) 
Children and 
adolescents with 
suicidal ideation 
only (N = 74), 
suicide attempt (N = 
49), and non-
suicidal (N = 
1,335). 
Attempters distinguished 
from ideators by female 
gender and substance use. 
Comorbidity not 
assessed; lethality of 
attempt not 
differentiated. 
 
Depressive disorders.  Depressive disorders fall under the broader category of 
mood disorders in the DSM-IV-TR (American Psychiatric Association, 2000).  The mood 
disorder category includes those disorders where the primary symptom is a disturbance in 
mood.  Once subset of mood disorder diagnoses includes depressive disorders, which are 
characterized by depressed mood, reduced interest in activities that used to be enjoyed, 
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sleep disturbance, loss of energy, difficulty concentrating, and/or suicidal thoughts or 
intentions (APA, 1994). 
Depression is arguably the biggest diagnostic risk factor for adolescent suicide 
(Fordwood et al., 2007; Kelly et al., 2001; Renaud et al., 2008).  However, depression 
alone does not predict which suicidal adolescents make lethal suicide attempts (Wetzler 
et al., 1996), suggesting that there are other psychopathological risk factors, as well as 
reasons beyond psychopathology, that distinguish suicide completers from attempters.  In 
the most recent study on adolescent suicide attempters that differentiated between both 
psychopathology and medical lethality, Nasser and Overholser (1999) found significant 
differences in suicide attempt lethality for adolescents with comorbid psychiatric 
diagnoses.  They examined psychopathological differences between non-lethal (N = 20), 
low-lethal (N = 20), and high-lethal (N = 20) adolescent suicide attempters, using the 
Lethality of Suicide Attempt Rating Scale (LSARS) (Smith, Conroy, & Ehler, 1984).  
They found the high-lethal group to be the only group that had several individuals 
diagnosed with a major depressive episode and comorbid attention deficit disorder 
(Nasser & Overholser, 1999).  Many adolescent suicide attempts are unplanned and made 
impulsively (Brown, Overholser, Spirito, & Fritz, 1991), making the propensity for 
impulsive and disruptive behaviors in the context of a mood disturbance especially 
concerning.  This inability to control aggressive impulses may even be a greater indicator 
of risk for impulsive suicide attempts than depression (Simon et al., 2001). 
Bipolar disorders.  Bipolar disorders also fall under the broader category of mood 
disorders in the DSM-IV-TR (APA, 2000).  For a diagnosis of bipolar disorder, a person 
must have had at least one manic or hypomanic episode in addition to a major depressive 
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episode.  Manic episodes are characterized by racing speech and thoughts, increased 
energy, decreased need for sleep, elevated mood and exaggerated optimism, increased 
physical and mental activity, excessive irritability, aggressive behavior, poor judgment, 
reckless behavior, difficulty concentrating, and inflated sense of self-importance.  
Because bipolar disorders have symptoms distinct from depressive disorders, and can be 
viewed as more externalizing than the typical internalizing symptoms of depression, it is 
important to consider the disorders separately in adolescent suicide research. 
Considering the role of bipolar diagnoses in adolescent suicide attempts is critical, 
as the recognition, diagnosis, and treatment of the disorder has increased in the last 
decade.  Because the knowledge base surrounding bipolar disorder is still 
underdeveloped, little is known about its relationship with adolescent suicidal behavior 
(Goldstein et al., 2005), and even less is known about the relationship between suicide 
attempt lethality and psychopathological comorbidity with the disorder.  This is likely 
because many studies on adolescent suicide attempts exclude subjects with bipolar 
diagnoses either because they are examining comorbidity with depression alone or 
because the sample size of bipolar subjects is not large enough to draw conclusions about 
the population. 
Some adult studies have found bipolar disorder to be over-represented in suicide 
attempts of high lethality, suggesting the risk of suicide completion is higher in patients 
with bipolar disorder (Raja & Azzoni, 2004); however, findings on the relationship 
between pediatric bipolar and suicide are mixed.  In a study comparing adolescent suicide 
completers with medically serious attempters, Beautrais (2003) found that child, 
adolescent, and young adult suicide completers were significantly more likely to have a 
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diagnosis of bipolar disorder than attempters.  However, Nasser and Overholser (1999) 
found no significant differences in the medical lethality of suicide attempts of adolescents 
with bipolar disorders when compared to those with depressive disorders.  Due to the 
scarcity of research on the impact of psychopathological comorbidity with bipolar 
disorder on suicide attempt lethality in the adolescent population, there is scant 
knowledge in this area.  However, in a study of adolescent suicide attempts that did not 
measure lethality, Kelly, Cornelius, and Lynch (2002) found bipolar disorder to be the 
one non-substance-related psychiatric disorder that places adolescents most at risk for 
attempted suicide. 
Disruptive disorders.  Disruptive disorders include, but are not limited to, such 
diagnoses as attention deficit hyperactivity disorder (ADHD), oppositional defiant 
disorder (ODD), and conduct disorder (CD) (APA, 2000).  These disorders have 
impulsive and externalizing characteristics that are not inherent in mood disorders, but 
when added as a secondary diagnosis, contribute a dangerous component to the 
psychopathological risk profile of the suicidal adolescent.  Aside from the findings of the 
Nasser and Overholser (1999) study, there is no other research that specifically examines 
the impact of psychopathological comorbidity with disruptive disorders on suicide 
completion or suicide attempt lethality in adolescents.  However, in support of this idea, 
there are some broader studies that suggest co-occurring disruptive and depressive 
disorders are significant indicators of risk for suicide attempts in adolescents. 
A study by Fordwood et al. (2007) found externalizing behaviors to be the 
strongest unique predictor of suicide attempts after accounting for the severity of 
depressive symptoms.  Penn and colleagues (2003) found that incarcerated adolescents 
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with conduct problems have higher rates of suicide attempts and use more violent 
methods than adolescents in the general population.  In one study that examined the 
impact of disruptive disorders when comparing child and adolescent suicide completers 
with community controls, Renaud et al. (2008) found that depressive disorders, disruptive 
disorders, and substance abuse disorders were the only independent significant 
psychopathology predictors of child and adolescent suicide completion. 
Substance abuse disorders.  In addition to knowledge from the Renaud et al. 
(2008) study which found substance abuse disorders to be one of the few types of 
psychopathology that differentiated suicide completers from community controls, 
Fleischmann and colleagues (2005) found youths with substance abuse disorders to be 
five to ten times more likely to complete suicide.  Other research demonstrates a strong 
link between having a comorbid mood and substance abuse disorder and completed 
suicide in adolescents.  In a psychological autopsy study, Portsky, Audenaert, and van 
Heeringen (2005) found substance abuse to be the secondary diagnosis to a mood 
disorder in 9 of 19 adolescent suicide completers.   
Research on the impact of psychopathological comorbidity with substance abuse 
on adolescent suicide attempt lethality is sparse.  In one of the few prior studies with 
youth that examined both suicide attempt lethality and psychopathological comorbidity, 
Brent (1987) found comorbid mood and substance abuse disorders to be predictive of 
suicide attempts of higher lethality.  Although there are no other studies that specifically 
measure suicide attempt lethality, there is other research that demonstrates substance 
abuse disorders to be significantly associated with adolescent suicide attempts (Epstein & 
Spirito, 2009).  Specifically, having an inhalant use, cocaine use, or hallucinogen use 
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disorder has been found to be predictive of attempted suicide in adolescents (Kelly, 
Cornelius, & Lynch, 2002).  Wu and colleagues (2004) found suicide attempts to be 
strongly associated with alcohol abuse and dependence, even after controlling for 
depression.  In a study of children and adolescents with bipolar disorder, it was found that 
bipolar suicide attempters were more likely to have a history of a substance abuse 
disorder when compared with bipolar non-attempters (Goldstein et al., 2005). 
Lethality and Other Risk Factors 
In addition to the presence and severity of psychopathology, there are numerous 
other factors that influence the lethality of adolescent suicide attempts.  In investigating 
the impact of comorbid psychiatric diagnoses on suicide attempt lethality, it is especially 
important to take the variables of gender, age, and race into account.  Prior research 
demonstrates that these demographic groups have diverse psychopathological 
experiences as well as differing suicide attempt and completion rates within the 
adolescent population.  Therefore, it is possible that certain typologies of psychiatric 
diagnoses and patterns of comorbidity have different effects on the medical lethality of 
adolescent suicide attempts across various gender, age, and race groups. 
Lethality and gender.  Epidemiological studies consistently demonstrate that 
female adolescents attempt suicide more frequently than males, and that male adolescents 
are more likely to complete suicide than females (CDC, 2007).  Beautrais (2003) 
similarly found male gender to be a predictor of suicide completion when compared to 
suicide attempts of high medical lethality.  However, after controlling for suicide attempt 
method, she found these differences to be explained by method choice, with males using 
more lethal means, which has been echoed in prior studies (Brent, Baugher, & Bridge et 
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al., 1999).  This finding becomes concerning in light of recent statistics which reveal an 
increase in lethal suicide attempt methods by adolescent females of hanging, suffocation, 
and poisoning (CDC, 2007).  This finding demonstrates that the more violent means of 
suicide attempts historically adopted by males and the more passive means of self-
destruction utilized by females (Portes et al., 2002) may be changing.  The likelihood of 
completion of a suicide attempt is largely about the chosen means; therefore, the recent 
adoption of more lethal suicide attempt methods puts females at greater risk of suicide 
completion, and raises concern that the adolescent female suicide rate may meet or even 
exceed that of males (Beautrais, 2003).  Changes in gender roles may also serve to 
narrow the gap between male and female suicide rates, as females take on more 
traditionally male-oriented characteristics (Portes et al., 2002). 
Prior research has also shown statistical associations between psychopathology 
and suicide attempts to be moderated by gender.  For instance, Brezo and colleagues 
(2007) found psychiatric comorbidity to have a significant effect on suicide attempts for 
females but not for males.  Kelly and colleagues (2001) found female adolescents with 
comorbid alcohol use and conduct disorders to be three times more likely to have 
attempted suicide than those with only one diagnosis.  Similarly, Wannan and Fombonne 
(1998) found substance abuse to be a significant predictor of adolescent suicidal behavior 
for both genders, but depression had significant interaction effects with substance abuse 
and conduct disorder for females only.  Also notable is that in an adult sample, Verona, 
Sachs-Ericsson, and Joiner (2004) found the co-occurrence of internalizing and 
externalizing disorders to play more of an influential role in suicide attempts among 
females than males.  Most recently, Webb (2009) conducted a literature review in which 
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she found young female substance abusers to present with more frequent and severe 
psychopathological comorbidity that suggests they are at increased risk for suicide.  From 
her findings she proposes that female gender can no longer be accepted as a protective 
factor for suicide completion. 
In sum, research demonstrates that psychopathological comorbidity may have a 
larger effect on suicide attempt risk for adolescent females than males.  The next step in 
understanding this relationship is to examine if various patterns of psychopathological 
comorbidity have significantly different links with suicide attempt lethality across 
gender.  Prior studies have not had a sample size large enough to make cross-gender 
comparisons, and have not had the ability to specifically measure suicide attempt 
lethality.  Research that accounts for gender differences in suicidal behaviors can enhance 
our understanding of adolescent suicide and will likely result in more focused adolescent 
suicide prevention efforts (Kelly et al., 2001). 
Lethality and age.  In addition to gender, age is another demographic variable 
with significant implications for adolescent suicidal behavior.  As stated by Portes, 
Sandhu, and Longwell-Grice (2002), “the adolescent’s egocentric, rigid here-and-now 
perspective reflects an inability to utilize his or her growing cognitive competencies” 
(809).  Adolescence marks a period of intellectual transition and instability, contributing 
to a limited ability to project themselves and others into the future (Portes et al., 2002).  
Because of these deficiencies, impulsivity can play a much larger role in the outcome of 
suicide attempts for adolescents than for adults.  The permanency of death may not be 
comprehended in adolescence (Portes et al., 2002), and adolescents are significantly less 
certain of the possible fatal outcome of their suicide attempt than adults (Parellada et al., 
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2007).  Because adolescents do not have the same knowledge of the lethality of different 
methods of attempting suicide as adults (Nasser & Overholser, 1999), we can posit that 
the impulsive adolescent or the adolescent impaired by substances is at greater risk for 
unintentionally making a lethal attempt. 
Due to the differences in cognitive capacities between younger and older 
adolescents, we can surmise that younger adolescents (ages 13 to 15) may be at greater 
risk than older adolescents (ages 16 to 18) for making a suicide attempt of high lethality 
that is unintentional.  While the older adolescent suicide attempter may be clear about his 
or her intention to die, the younger adolescent may not adequately understand the concept 
of death and likely has not fully considered the options, risks, consequences, and benefits 
of suicide.  And perhaps more importantly, it is likely that younger adolescents have less 
knowledge about the lethality of chosen means, making them more vulnerable to 
unintentional attempts of high lethality.  In support of the influence of cognitive 
differences on suicidal behaviors, Nrugham, Larsson, and Sund (2008) found that having 
a depressive disorder predicts suicidal acts for older adolescents, but not for younger 
adolescents.  This finding suggests that for younger adolescents, there may be a profile of 
psychopathology other than depression that puts them at greater risk for a suicide attempt 
than their older adolescent counterparts.  It is possible that because of the continuous 
development of cognitive skills within the adolescent period, younger adolescents 
diagnosed with externalizing or impulsive disorders may be at greater risk of making 
lethal suicide attempts than older adolescents. 
Lethality and race.  In addition to gender and age, the variable of race is 
important to consider in the relationship with suicide attempt lethality.  It is unclear at 
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this point if this relationship differs across race; however, further investigation is 
warranted to determine if race is associated with the lethality of suicide attempts.  Race 
comparisons of adolescent suicidal behavior have rarely been conducted with adequate 
sample sizes from which to draw conclusions, as the majority of adolescent suicide 
research has involved predominately Caucasian samples (Langhinrichsen-Rohling, 
Friend, & Powell, 2009).  Epidemiological data on race differences in adolescent suicide 
completion rates show that White adolescents have had a higher rate of suicide than both 
Hispanic and Black older adolescents, with Black older adolescents having the lowest 
suicide rate of all race groups.  However, suicide attempt rates demonstrate a very 
different race pattern, as Hispanic adolescents have had the highest attempt rate, followed 
by Blacks, and then Whites with the lowest rate (Wagner, 2009). 
While there do not exist prior studies that specifically investigate the relationship 
between race and suicide attempt lethality in adolescents, previous research exploring 
race in relation to adolescent suicidal behaviors are on the whole inconclusive.  Using 
secondary data from the 2007 Youth Risk Behavior Survey, Kim (2010) found that race 
was not a good predictor of adolescent suicidal behaviors.  In a study of depressed 
adolescent primary care patients who attempted suicide, Fordwood and colleagues (2007) 
found that race was not significantly related to suicide attempts.  There is some other 
research that suggests cultural differences in risk factors for suicide do exist.  For 
instance, Blum and colleagues (2000) found that White adolescents were more likely to 
attempt suicide in the younger years than Black or Hispanic youth.  Race requires further 
study in adolescent suicide research because it is unclear if race differences in risk factors 
for suicide exist in this population.  While prior studies have included race as a control 
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variable in predictive models of suicidal behavior, this does not inform us about whether 
or not suicidal processes vary by race (Watt & Sharp, 2002).  Although there have been 
some small scale studies on risk factors for adolescent suicidal behaviors within specific 
cultural groups, few of these studies have included cross-cultural comparisons, which are 
necessary in order to build knowledge about race differences in risk factors for adolescent 
suicide. 
 
Study Significance  
Mental health professionals are not able to predict the occurrence of adolescent 
suicide attempts with high accuracy, largely because there are multiple pathways to the 
common endpoint of suicide in adolescents (Wagner, 2009).  Research findings on 
adolescent suicide can be misleading because studies often place all suicidal behaviors in 
the same category, regardless of the medical lethality of the behavior.  For instance, many 
studies will include both non-suicidal self-injury and highly lethal suicide attempts under 
the same construct of suicidality when looking at risk factors.  This is an enormous 
methodological weakness, as an adolescent who scratches herself on the forearm in a 
moment of distress cannot be theoretically compared to an adolescent who has made a 
suicide attempt with lethal means such as a firearm.  These variations make it difficult to 
draw general conclusions about risk factors for adolescent suicide in studies that do not 
specify medical lethality.  Research methodologies that account for differences in levels 
of lethality can help specify risk factors and will contribute to more effective adolescent 
suicide prevention efforts (Kelly et al., 2001). 
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Psychopathology is another construct that has been poorly defined in prior studies 
on adolescent suicide.  Prior research has not always specified the type of psychiatric 
disorder associated with suicide risk, and very few studies have examined the co-
occurrence of psychiatric diagnoses.  In order to best understand the role of 
psychopathology in explaining adolescent suicide, both the suicidal behavior and the 
psychopathology must be specified.  Prior researchers have attempted to do this using 
psychological autopsy studies.  However, autopsy studies are limited in what they can 
explain about the psychopathology of adolescent suicide completers, as psychiatric 
evaluations prior to the suicide are rarely available.  Autopsy studies rely upon 
retrospective examinations of completed suicides that use information from secondary 
sources.  Autopsy studies can over-diagnose depression and other mood disorders, which 
may introduce bias into the assessment and diagnosis of psychopathology of the suicide 
completer, leading to a cautious interpretation of the results (Portsky et al., 2005).  
Because of the limitations inherent in psychological autopsy studies, the assessment of 
specific typologies of psychiatric disorders in adolescent suicide attempts of high 
lethality is critical to the understanding of risk factors for adolescent suicide.  Due to 
sample size limitations, recent research has not explicitly examined differences in 
psychopathology across varying levels of medical lethality of adolescent suicide 
attempts.  Even the older research conducted by Nasser and Overholser (1999) did not 
have a sample size large enough to conduct a regression analysis, which would have been 
more explanatory than the bivariate analyses they utilized. 
Research that includes highly lethal attempters, differentiates between psychiatric 
typologies, and uses advanced statistical analysis will expand our understanding of 
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psychopathological risk factors for adolescent suicide.  The strength of this study is that it 
has a sample size large enough to break down the construct of the suicide attempt into 
different levels of medical lethality and the construct of psychopathology into specific 
typologies and comorbidity patterns of psychiatric disorders.  In doing so, this study 
enables us to look at the psychopathological risk factors for adolescent suicide attempts 
in a new way.  It allows us to see if suicide attempts of high lethality, which we can 
compare most closely with suicide completion, are associated with different typologies 
and combinations of psychiatric disorders than those suicide attempts that are non-life-
threatening.  By making up for past methodological limitations, this study adds to the 
existing knowledge base to help inform adolescent suicide risk assessment, treatment, 
and prevention practices. 
This study also contributes to our understanding of the impact of 
psychopathological indicators on suicide attempt lethality across the demographic groups 
of gender, age, and race.  While gender differences in risk factors for adolescent suicide 
are understood, the interplay between gender and psychopathology is much less clear.  
The large sample size in this study allows us to examine differences in psychopathology 
across gender to see how it impacts suicide attempt lethality.  An additional strength of 
the study is that it enables us to look at adolescence not just as one age group, but instead 
as a period of transition that can have different implications on the medical seriousness of 
suicide attempts.  Breaking down the construct of adolescence into younger and older age 
groups allows for a more specific examination of the relationship between 
psychopathology and suicide attempt lethality across age.  Having a large sample from a 
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city hospital also allows for comparisons to be made across multiple races, which has not 
been possible in previous studies. 
 
Hypotheses 
To address the aims of this study, seven hypotheses (H) were tested: 
H1:  Adolescents diagnosed with a Depressive Disorder do not make suicide attempts of 
higher lethality than adolescents without a Depressive Disorder. 
H2:  Adolescents diagnosed with a Disruptive Disorder do not make suicide attempts of 
higher lethality than adolescents without a Disruptive Disorder. 
H3:  Adolescents diagnosed with a Substance Abuse Disorder make suicide attempts of 
higher lethality than adolescents without a Substance Abuse Disorder. 
H4:  Adolescents diagnosed with a Disruptive or Substance Abuse Disorder, in addition 
to a Depressive Disorder, make suicide attempts of higher lethality than adolescents with 
a Depressive Disorder alone. 
H5:  Adolescents diagnosed with a Disruptive or Substance Abuse Disorder, in addition 
to Bipolar or Mood Disorder NOS, make suicide attempts of higher lethality than 
adolescents with Bipolar or Mood Disorder NOS alone. 
H6:  Having a diagnosis of a Disruptive or Substance Abuse Disorder, in addition to a 
Depressive Disorder, has a stronger effect on suicide attempt lethality for adolescent 
females than adolescent males. 
H7:  Having a diagnosis of a Disruptive or Substance Abuse Disorder, in addition to a 
Depressive Disorder, has a stronger effect on suicide attempt lethality for younger 
adolescents than older adolescents. 
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 Although current literature does not support a hypothesis specific to the 
relationship between race and suicide attempt lethality in adolescents, the relationship 
between race and suicide attempt lethality will be investigated. 
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CHAPTER II 
 
Methodology 
Study Design and Sample 
This study used a chart review to examine the relationship between 
psychopathological comorbidity and the medical lethality of adolescent suicide attempts.  
The research design was quantitative and explanatory in nature.  A basic power analysis 
yielded an N of 271, with sufficient power to include approximately 30 covariates 
(Decision Support Systems, LP, 2010).  For regression analyses, a strategy developed by 
Green (1991) suggests that N > 50 + 8m (where m is the number of covariates) for testing 
multiple correlations.  This would suggest the need for an N of 290 for 30 covariates. 
Data were collected from psychiatric evaluations of all adolescents that presented 
to Children’s Hospital Boston (CHB) from 2006 to 2010 for a suicide attempt (N = 380).    
Adolescent suicide completers were not included in this study.  The sample included 
subjects between 13 and 18 years of age at the time of evaluation.  Exclusions were 
subjects with mental retardation (N = 1), subjects for whom it was unclear whether or not 
the self-injurious behavior was a suicide attempt (N = 3), and subjects for whom data 
were missing regarding the dependent variable of suicide attempt lethality (N = 1).  There 
were no missing independent variable data in this study.  Taking the five exclusions into 
account, the final analytic N was 375.  There were a small number of repeat attempters in 
this study; considering these, the overall patient total was N = 362.  Repeat patients were 
given the same case ID but were treated as multiple cases, as psychiatric diagnoses and 
suicide attempt lethality can evolve, making it possible for patients to have very different 
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profiles at two points in time.  Additionally, repeat attempters were not dropped because 
it could not be determined if any of the other attempters in the study had multiple suicide 
attempts which were previously treated at different hospitals.  White correction for 
standard errors was used to address the issue of correlation of multiple observations from 
the same patient (White, 1980). 
Data Collection 
A chart review was conducted to collect data for the variables of suicide attempt 
lethality, psychopathology, gender, age, and race.  The data for the independent variables 
were all found in the content of the psychiatric evaluation.  The dependent variable of 
medical lethality of the suicide attempt was collected for each subject using the Lethality 
of Suicide Attempt Rating Scale II (LSARS-II) (Berman, Shepherd, & Silverman, 2003) 
(See Appendix A).  Psychiatric evaluations and medical notes for all subjects were 
reviewed by the principal investigator to assess the lethality of the suicide attempt using 
the LSARS-II scale.  LSARS-II scores for subjects in this study were assessed based 
upon detailed information about the medical lethality and circumstances of the suicide 
attempt found in both the psychiatric evaluation and medical documentation.  To enhance 
the reliability and validity of the assessment tool, a research assistant also independently 
rated the lethality of the suicide attempt for 50% of the subjects using the LSARS-II and 
compared her results to the results of the principal investigator.  Prior to data collection, 
in order to train for the use of the LSARS-II, the principal investigator and research 
assistant first reviewed the scale together and then practiced using a few 2011 evaluations 
that would not be used in the study.  In the data collection process, for 50% of the 
subjects, they reviewed and rated the psychiatric evaluations and medical notes 
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separately.  The raters achieved exact agreement on 85% of the evaluations that they both 
reviewed.  They discussed the remaining 15% by reviewing the contents of the 
psychiatric evaluation and medical documentation together to decide on a value for those 
scores.  To decrease bias, the lethality of the suicide attempt was assessed first for all 
subjects prior to documenting their psychopathology, so that the knowledge of 
psychopathology would not influence the raters’ decision about the lethality of the 
attempt.  Once all data were collected, the dataset was de-identified and compiled into a 
separate dataset for analysis.  The data entry form used for the data collection process can 
be found in Appendix B. 
Measurement 
Suicide attempt lethality.  The dependent variable in this study is the medical 
lethality of the adolescent suicide attempt, which was measured using the LSARS-II.  
The LSARS-II was updated from the LSARS, which was developed as a tool to 
objectively measure the medical lethality of a suicide attempt (Smith, Conroy, & Ehler, 
1984).  The updated LSARS-II includes a completely revised and redesigned table of 
drugs and chemicals.  This revision was imperative for two reasons; the need for an 
updated table incorporating more current medications, and the necessity of a new format 
to evaluate toxicity given the difficulty in determining the minimum lethal dose of an 
ingested substance in humans (Berman et al., 2003).  In the LSARS-II, the lethality of the 
suicide attempt is rated on an 11-point scale ranging from 0, where “death is an 
impossible result,” to 10, where “death is almost a certainty.”  The scale includes 
comprehensive descriptions and examples of suicide attempt methods, as well as a table 
of drug and substances and their lethal doses for two different body weights.  The 
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lethality of the suicide attempt is measured as a single rating which reflects both the 
medical lethality, and the circumstances of the attempt.  The fact that circumstances are 
included speaks to the clinical utility of the instrument to the assessment of suicide risk, 
as it integrates the role of suicidal intent in the lethality of the attempt (Berman et al., 
2003). 
While a number of scales to measure lethality have been used in prior studies, 
only three have published data on their psychometric properties.  While all three of thee 
scales have good concurrent validity and inter-rater reliability (Goldston, 2003), the 
LSARS is arguably superior.  The reason for this is twofold: it provides a broader range 
of reference points for decision markers regarding levels of risk which allows for much 
greater empirical and clinical sensitivity, and it includes an extensive table of lethal levels 
of ingested substances (Berman et al., 2003).  The LSARS and LSARS-II have 
demonstrated good inter-rater reliability in prior studies, with intra-class correlation 
coefficients between 0.80 and 0.90 (Nasser & Overholser, 1999; Smith et al., 1984).  
Important to this study is the fact that the LSARS-II has been used with adolescent 
populations (Nasser & Overholser, 1999).  One issue with the use of the LSARS-II is that 
if multiple substances are ingested the interpretation of the scale becomes more difficult 
(Berman et al., 2003). 
Demographic variables.  In this study, gender was made into a dichotomous 
variable (1 = Male, 0 = Female).  Age was made into both a continuous and dichotomous 
variable, with 13-15 years representing one group and 16-18 years representing another 
group (1 = Younger, 0 = Older).  There were no issues of validity or reliability for gender 
or age variables.  Race was coded categorically (1 = Caucasian/White, 2 = African-
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American/Black, 3 = Hispanic/Latino, 4 = Asian, 5 = Biracial, 6 = Other).  The Biracial 
category included all adolescents who identified themselves as a combination of two or 
more race groups.  Due to small numbers in the Asian, Biracial, and Other categories, 
they were collapsed into the same group for bivariate and multivariate analysis.  The race 
categories do pose some threats to reliability and validity.  The Other category was not 
always specified by the evaluator, and therefore it was not possible to get an accurate race 
description for those subjects.  An additional limitation of the study is that it was not 
possible to measure socioeconomic status (SES).  Lack of SES measurement is not only a 
limitation in itself, but also affects the interpretation of race in this study.  SES interacts 
with and confounds analyses of race and gender, with a growing body of research 
suggesting its influence on child health outcomes (American Academy of Pediatrics, 
2000).  Therefore, any findings in this study with respect to the variable of race must be 
interpreted with caution, as it was not possible to control for SES when analyzing race 
effects. 
Suicide attempt method.  The variable of suicide attempt method was also 
collected in this study (1 = Ingestion/poisoning, 2 = Cutting, 3 = Suffocation, 4 = 
Strangulation, 5 = Jumping, 6 = Hanging, 7 = Firearm, 8 = Swallowing of Object, 9 = 
Electrocution, 10 = Drowning).  If two attempt methods were used, the last method used 
was recorded.  For instance, if an adolescent first attempted by ingestion without any 
effect and then decided to self-strangulate, the strangulation would be considered as the 
method used. 
Psychopathology and comorbidity.  The primary independent variables of analysis 
in this study were psychopathology and psychopathological comorbidity.  Psychiatric 
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disorders were first defined and categorized in terms of Diagnostic and statistical manual 
of mental disorders (4th ed., Text Revision) (DSM-IV-TR) criteria, and then recorded into 
dichotomous categories, where subjects could meet criteria for more than one disorder 
simultaneously (1 = Yes, 0 = No) (APA, 2000).  Diagnoses were generalized into the 
following DSM-IV-TR categories: Depressive, Bipolar, Mood Disorder NOS, Disruptive, 
Substance Abuse, Anxiety, and Other.  Diagnoses which were not definitive, such as 
rule-out diagnoses, were not included in analysis.  Additionally, personality disorders 
were not included in analysis, as the DSM-IV-TR criteria maintain that an individual must 
be 18 years of age to receive such a diagnosis.  All subjects in this study carried at least 
one psychiatric diagnosis. 
After frequencies were collected, attempters with Mood Disorder NOS were 
combined with attempters diagnosed with a Bipolar Disorder, into a new variable named 
Bipolar or Mood Disorder NOS.  Mood disorder NOS is diagnosed when the primary 
symptom is a problem of mood, but the symptomatology does not fit into a specific mood 
disorder category.  This diagnosis is typically given when it is difficult to choose between 
depressive and bipolar disorders, usually because there is an externalizing or impulsive 
component to the symptomatology (APA, 2000).  Therefore, because of this externalizing 
component, attempters diagnosed with either bipolar disorder or mood disorder NOS 
were combined into the same category for analysis. 
The diagnoses used in this study had already been determined by CHB psychiatric 
clinicians following interviews with the patient, family members, and other collateral 
contacts.  The reliability of raters in this study was unable to be assessed, as the study is 
retrospective and not all raters still work at CHB.  While all CHB clinicians diagnose 
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their patients in accordance with DSM-IV-TR criteria, it must be noted that this 
assessment procedure may lead to a certain degree of diagnostic uncertainty and may 
cause comorbid diagnoses to be under-recognized.  Because of this, the impact of 
comorbidity on the lethality of the suicide attempt may be underestimated.  To address 
this limitation, documented histories of prior psychiatric diagnoses, even if not diagnosed 
at time of psychiatric evaluation, were noted as prior diagnoses in this study, and were 
included as indicators in bivariate and multivariate analysis. 
To test comorbidity hypotheses, dichotomous variables were made to represent 
that the subject met criteria for certain disorders simultaneously (1 = yes, 0 = no).  For 
bivariate analyses, six comorbidity variables were created: Depressive and Disruptive, 
Depressive and Substance Abuse, Depressive and Disruptive and Substance Abuse, 
Bipolar or Mood NOS and Disruptive, Bipolar or Mood NOS and Substance Abuse, and 
Bipolar or Mood NOS and Disruptive and Substance Abuse.  For multivariate analyses, 
due to inadequate numbers, only two comorbidity variables were created: Depressive and 
Disruptive or Substance Abuse, and Bipolar or Mood NOS and Disruptive or Substance 
Abuse. 
It is important to address the issues of validity and utility in research involving 
psychiatric diagnoses.  While the validity of medical syndromes is rarely contested, 
psychiatric disorders face different challenges in research and practice.  Psychiatric 
disorders often have overlapping symptoms, making it difficult to determine an 
appropriate diagnosis.  Clinicians do not always report comorbid disorders when 
evaluating suicidal patients, likely because the mood disorder tends to be primary and 
may appear to overshadow other symptomatology at the time of the patient’s 
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presentation.  Because of this, comorbid diagnoses are often under-recognized (Nasser & 
Overholser, 1999), which contributes to limitations in both practice and research.  
Despite the problems involved in distinguishing one psychiatric disorder from another 
and in resolving issues of comorbidity, the utility of using diagnostic criteria in 
psychiatric research is invaluable and must be recognized (Kendell & Jablensky, 2003).  
Such research can inform etiology, risk factors, and outcomes, as well as help clinicians 
to make decisions about symptom management and treatment (Spitzer, 2001).  Therefore, 
it is appropriate for most psychiatric research to be based on precisely defined disorders, 
whether or not they have been shown to be valid (Kendell & Jablensky, 2003). 
Statistical Analysis 
 Data analysis was conducted using the STATA 11.0 statistical package.  The first 
step of the data analysis process included a descriptive analysis of each of the variables 
via frequency distributions.  Second, bivariate tests were run to determine if statistically 
significant relationships existed between each of the independent variables and the 
dependent variable of suicide attempt lethality.  Independent t-tests, Pearson correlation, 
and one-way ANOVA were used to determine if there were statistically significant 
differences in means of the LSARS-II scores for the different independent variable 
groups.  Third, ordinary least squares (OLS) regression was used to determine the percent 
of variance in the dependent variable explained by the independent variables and to rank 
the relative importance of the independents.  Despite the fact that there were few 
independent variables and the dependent variable can only be positive, OLS is still a 
good reduced form model for data analysis.  OLS is good model to use when there is no 
multicollinearity, and can be used as a maximum likelihood estimator when errors are 
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normally distributed.  However, the method has good statistical properties for a much 
broader class of distributions.  In this study, White standard error adjustments were used 
to correct for correlations created by repeated observations for subjects (White, 1980). 
To test the first three hypotheses, OLS regression analysis was performed with the 
independent variables of gender, age group, race, and specific psychiatric diagnoses.  Due 
to multicollinearity issues, psychiatric diagnoses were entered one psychopathology 
variable at a time.  The next set of models used the psychopathological comorbidity 
variables to test the fourth and fifth hypotheses.  To test the fourth hypothesis a subset of 
attempters with Depressive Disorders was used, and to test the fifth hypothesis a subset 
of attempters with Bipolar or Mood Disorder NOS was used.  The sixth and seventh 
hypotheses posited that gender and age may alter the strength of the causal relationship 
between psychopathological comorbidity and lethality; thus, moderating effects were 
examined.  A moderating variable is a variable that alters the strength of a causal 
relationship (Baron & Kenny, 1986).  To assess moderation, regressions were run for 
gender and age groups separately using the psychopathological comorbidity variables.  In 
addition, interaction terms were made between gender and psychopathological 
comorbidity, as well as age group and psychopathological comorbidity, and were used in 
OLS regression analysis to examine the moderating effect of gender and age group 
differences as they influence the link between psychopathological comorbidity and 
suicide attempt lethality.  It is important to note that in order to have reasonable power to 
detect moderating effects when one of the variables is continuous, a sample size of at 
least 200 is needed (Aguinis, 2004). 
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CHAPTER III 
 
Results 
Frequencies 
Demographics.  In the sample, there were 85 males (22.7%) and 290 females 
(77.3%).  This study used adolescents ranging in age from 13 to 18 years (x¯  = 15.42; SD 
= 1.34).  Adolescents were broken down into age groups for this study; there were 183 
attempters in the range of 13 to 15 years (48.8%) and 192 between the age of 16 to 18 
years (51.2%).  The frequencies for race included Caucasian/White (250; 66.7%), 
Hispanic/Latino (56; 14.9%), African-American/Black (36; 9.6%), Biracial (21; 5.6%), 
other (8; 2.1%), and Asian (4; 1.1%).  The Biracial category included all adolescents who 
identified themselves as a combination of two or more race groups.  Due to low numbers 
in the categories of Asian, Biracial, and Other, the groups were combined together under 
the “Other” category (33; 8.8%) for bivariate and multivariate analysis.  Table 2 
summarizes the frequencies of the demographic variables. 
Table 2 
Frequencies of Demographics (N = 375) 
Demographic Variable Category Frequency 
Gender  Male 
Female 
85; 22.7% 
290; 77.3% 
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Age 13   
14   
15   
16   
17   
18  
38; 10.1% 
56; 14.9% 
90; 24.0% 
107; 28.5% 
66; 17.6% 
18; 4.8% 
Age Group 13-15  
16-18  
183; 48.8% 
192; 51.2% 
Race Caucasian/White 
Hispanic/Latino   
African-American/Black   
Biracial   
Other   
Asian   
250; 66.7% 
56; 14.9% 
36; 9.6% 
21; 5.6% 
8; 2.1% 
4; 1.1% 
 
Suicide attempt method.  Frequencies of suicide attempt method were also 
examined.  Ingestion/poisoning (327; 87.2%) was the leading suicide attempt method, 
followed by cutting (14; 3.73%), strangulation (12; 3.20%), hanging (10; 2.67%), 
jumping (7; 1.87%), suffocation (1; 0.27%), firearm (1; 0.27%), swallowing of object (1; 
0.27%), electrocution (1; 0.27%), and drowning (1; 0.27%). 
Psychopathology.  The frequencies of psychopathological disorders were 
examined.  Depressive Disorders (272; 72.5%) were the most prevalent, followed by 
Disruptive Disorders (135; 36.0%), Substance Abuse Disorders (106; 28.0%), Mood 
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Disorder NOS (70; 18.7%), Anxiety Disorders (61; 16.3%), Other Disorders (47; 12.5%), 
and Bipolar Disorders (17; 4.5%).  All subjects in this study carried at least one 
psychiatric diagnosis.  It is important to note that these groups were not mutually 
exclusive and the sum of the percentages did not equal 100 percent.  Table 3 summarizes 
the psychopathology frequencies. 
Table 3 
Frequencies of Psychopathology (N = 375) 
Psychopathology Variable Frequency 
Depressive Disorder 272; 72.5% 
Bipolar Disorder 17; 4.5% 
Mood Disorder NOS 70; 18.6% 
Disruptive Disorder 135; 36.0% 
Substance Abuse Disorder 106; 28.2% 
Anxiety Disorder 61; 16.2% 
Other Disorder 47; 12.5% 
 
Psychopathological comorbidity.  Psychopathological comorbidity frequencies 
were also observed in this study.  Attempters diagnosed with either Bipolar Disorder or 
Mood Disorder NOS (87; 23.1%) were combined into one category for all bivariate and 
multivariate analyses.  The psychopathological comorbidity pattern with the largest 
frequency was Depressive and Disruptive (77; 20.5%), followed by Depressive and 
Substance Abuse (59; 15.7%), Bipolar or Mood NOS and Disruptive (50; 13.3%), 
Bipolar or Mood NOS and Substance Abuse (41, 10.9%), Bipolar or Mood NOS and 
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Disruptive and Substance Abuse (31, 8.2%), and Depressive and Disruptive and 
Substance Abuse (25; 6.7%).  It is important to note that Substance Abuse was never the 
sole diagnosis for attempters in this sample; it was always comorbid with at least one 
other psychiatric disorder.  While there did exist other comorbidity patterns, these 
specific combinations were chosen to test the theoretically informed hypotheses of this 
study.  These groups were not mutually exclusive and the sum of the percentages did not 
equal 100 percent.  Table 4 summarizes the frequencies for psychopathological 
comorbidity. 
Table 4 
Frequencies of Psychopathological Comorbidity (N = 375) 
Psychopathological Comorbidity Variable Frequency 
Depressive and Disruptive 77; 20.5% 
Depressive and Substance Abuse 59; 15.7% 
Depressive and Disruptive and Substance Abuse 25; 6.7% 
Bipolar or Mood NOS and Disruptive 50; 13.3% 
Bipolar or Mood NOS and Substance Abuse 41; 10.9% 
Bipolar or Mood NOS and Disruptive and Substance Abuse 31; 8.2% 
 
Lethality.  The lethality of suicide attempts in this study ranged from 0.0 to 10.0 
(x¯  = 2.88; SD = 1.56).  The lethality variable was skewed left, as Figure 1 illustrates. 
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Figure 1 
Lethality Distribution 
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However, a plot of the studentized residuals demonstrated no clear pattern.  
Taking the log and square root of the lethality variable also made no changes in the 
pattern of the residuals.  Therefore, there was no indication that the variable required 
transformation in order to be used in the regression model; using robust estimation was 
adequate to address the issue of heteroskedasticity of the residuals.  The fact that these 
deviations existed suggests that there is little explanatory value in the regression models.  
This makes sense as the aim of this study was not to develop a comprehensive model of 
the predictors of suicide attempt lethality, but rather, to examine only certain 
demographic and psychopathological predictors. 
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Bivariate Tests 
 Demographics.  Independent t-tests, Pearson correlation, and one-way ANOVA 
were used to examine relationships between suicide attempt lethality and selected 
demographic variables.  Independent t-tests demonstrated that lethality was not 
significantly different between males and females.  Age group differences in lethality 
were not significant between the younger (x¯  = 2.78) and older (x¯  = 2.98) groups (t(df=373) 
= 1.23; p = 0.21).  The continuous age variable was also not significantly correlated with 
lethality (r = 0.04; p = 0.36).  One-way ANOVA demonstrated no significant difference 
in lethality across race groups (F(df=5) = 0.97; p = 0.43).  However, ANOVA 
postestimation showed trend level differences between the African-American/Black and 
Caucasian/White groups, with African-American/Blacks having lower lethality than 
Caucasian/Whites (F(df=5) = 3.54; p = 0.06).  Table 5 summarizes the results of the 
bivariate relationships between demographics and lethality. 
Table 5 
Bivariate Relationships between Demographics and Lethality (N = 375) 
Demographic Variable x¯  t/ F 
Gender  
    Male 
    Female 
 
3.04 
2.83 
-1.07 
Age Group 
    13-15 Years 
    16-18 Years 
 
2.78 
2.98 
1.23 
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Race 
    Caucasian/White 
    African-American/Black 
    Hispanic/Latino 
    Other 
 
2.94 a 
2.41 a 
2.78 
3.15 
0.97 
a Between group differences trend level significant at p<.10 
 Psychopathology.  Independent t-tests were used to examine relationships 
between lethality and the individual psychopathology variables.  For each t-test one 
psychopathology variable was compared to all others in the sample.  The only significant 
relationship with lethality was Substance Abuse, as adolescent suicide attempters with a 
Substance Abuse diagnosis had higher lethality scores than attempters without the 
diagnosis (x¯  = 3.22; t(df=373) = -2.65; p = 0.008).  Table 6 summarizes the results of the 
bivariate relationships between psychopathology and lethality. 
Table 6 
Bivariate Relationships between Psychopathology and Lethality (N = 375) 
Variable x¯  t 
Depressive 2.85 0.67 
Bipolar or Mood Disorder NOS 3.06 -1.24 
Disruptive 2.89 -0.08 
Substance Abuse 3.22 -2.65** 
Anxiety 3.03 -0.79 
Other 3.10 -1.02 
Total Sample 2.88  
**Significant at the p<.01 level 
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 Psychopathological comorbidity.  Independent t-tests were used to examine 
relationships between suicide attempt lethality and the psychopathological comorbidity 
variables.  For each t-test one psychopathological comorbidity variable was compared to 
all others in the sample.  Findings for lethality differences across psychopathological 
comorbidity were only significant for the relationships with Bipolar or Mood Disorder 
NOS and Substance Abuse (x¯  = 3.37; t(df=373) = -2.14; p = 0.03) and Bipolar or Mood 
Disorder NOS and Disruptive and Substance Abuse (x¯  = 3.46; t(df=373) = -2.16; p = 0.03).  
Attempters with those diagnoses had significantly more lethal attempts than attempters 
without the diagnoses.  Table 7 summarizes the results of the bivariate relationships 
between psychopathological comorbidity and lethality. 
Table 7 
Bivariate Relationships between Psychopathological Comorbidity and Lethality (N = 
375) 
Variable x¯  t 
Depressive and Disruptive 2.81 0.47 
Depressive and Substance Abuse 3.16 -1.46 
Depressive and Disruptive and Substance Abuse 3.16 -0.90 
Bipolar or Mood NOS and Disruptive 3.08 -0.93 
Bipolar or Mood NOS and Substance Abuse 3.37 -2.14* 
Bipolar or Mood NOS and Disruptive and Substance Abuse 3.46 -2.16* 
*Significant at the p<.05 level 
Multiple Regression 
Psychopathology and lethality.  The first set of regression models were used to 
test the first three hypotheses of the study: 
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H1:  Adolescents diagnosed with a Depressive Disorder do not make suicide attempts of 
higher lethality than adolescents without a Depressive Disorder. 
H2:  Adolescents diagnosed with a Disruptive Disorder do not make suicide attempts of 
higher lethality than adolescents without a Disruptive Disorder. 
H3:  Adolescents diagnosed with a Substance Abuse Disorder make suicide attempts of 
higher lethality than adolescents without a Substance Abuse Disorder. 
Since the psychopathology categories were not mutually exclusive, and due to 
multicollinearity problems from including dummy variables for all psychopathology 
variables in one model, it was determined that the optimal modeling strategy was to run 
six separate OLS regression models assessing the role of one psychopathology category 
at a time.  In these models, attempters with the designated psychopathological diagnosis 
were compared to all other attempters in the sample. 
The only demographic variable that showed a significant relationship with 
lethality was African-American/Black race, as it had a negative relationship with lethality 
in all psychopathology models tested (β = -0.52; p = .03 for Model 1) when compared to 
Caucasian/White race.  Post-hoc tests for race demonstrated one trend level significant 
group difference between the African-American/Black and Other race groups (F = 3.04; 
p = 0.07 for Model 1) in all models, with African-American/Blacks having significantly 
lower lethality than those in the Other race group.  The only significant 
psychopathological predictor of lethality was Substance Abuse, as adolescent suicide 
attempters with a Substance Abuse diagnosis had higher lethality scores (β = 0.42; p = 
.02) than the rest of the sample.  Table 8 summarizes results from the first set of 
regression models. 
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Table 8 
Multiple Regression on Lethality (N = 375) 
Variable Lethality 
(Model 1) 
Lethality 
(Model 2) 
Lethality 
(Model 3) 
Lethality 
(Model 4) 
Lethality 
(Model 5) 
Lethality 
(Model 6) 
 Β β β β β β 
Younger Age -0.23 -0.23 -0.22 0.16 -0.22 0.22 
Male Gender 0.21 0.22 0.20 0.17 0.21 0.20 
Af-Am/Black -0.52*a -0.51*a  -0.53*a -0.51*a -0.53*a -0.50*a 
Hispanic/Latino -0.11 -0.09 -0.13 -0.09 -0.12 -0.13 
Other Race 0.25a 0.25a 0.25a 0.25a 0.29a 0.26a 
Depressive -0.12      
Bipolar/Mood NOS  0.24     
Disruptive   0.01    
Substance Abuse    0.42*   
Anxiety     0.20  
Other Disorder      0.19 
F 1.54 1.81+ 1.33 2.80* 1.61 1.32 
R2 0.02 0.02 0.02 0.03 0.02 0.02 
+Trend level significant at p<.10 
*Significant at the p<.05 level 
a Between group differences trend level significant at p<.10 
Psychopathological comorbidity and lethality.  The next regression model was 
used to test the fourth hypothesis: 
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H4:  Adolescents diagnosed with a Disruptive or Substance Abuse Disorder, in addition 
to a Depressive Disorder, make suicide attempts of higher lethality than adolescents with 
a Depressive Disorder alone. 
This model included all attempters with a Depressive Disorder diagnosis that did 
not have a comorbid Anxiety or Other Disorder (N = 200).  This condensed the original 
sample into a subset of attempters with a Depressive Disorder only (N = 137) and 
attempters with a Depressive Disorder and either a comorbid Disruptive or Substance 
Abuse Disorder (N = 63).  A dummy variable was created for attempters with comorbid 
Depressive and Disruptive or Substance Abuse Disorders, leaving attempters with a 
Depressive Disorder only as the reference group.  Race groups did not have adequate 
numbers to be included in analysis.  The psychopathological comorbidity variable did not 
have a significant relationship with lethality in this model; however, male gender was 
found to have a positive relationship with suicide attempt lethality at trend level (β = 
0.53; p = .09).  Table 9 summarizes the results of the Depressive Disorder comorbidity 
regression model. 
Table 9 
Multiple Regression on Lethality, with Psychopathological Comorbidity, for Subset of 
Attempters with a Depressive Disorder (N = 200) 
Variable Lethality  
 β SE 
Younger Age Group (N = 99) -0.01 0.22 
Male Gender (N = 45) 0.53+ 0.31 
Depressive and Disruptive or Substance Abuse (N = 63) -0.08 0.24 
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F 0.95  
R2 0.02  
+Trend level significant at p<.10 
The next regression model was used to test the fifth hypothesis: 
H5:  Adolescents diagnosed with a Disruptive or Substance Abuse Disorder, in addition 
to a Bipolar or Mood Disorder NOS, make suicide attempts of higher lethality than 
adolescents with Bipolar or Mood Disorder NOS alone. 
This model included all attempters with Bipolar or Mood Disorder NOS that did 
not have a comorbid Anxiety or Other Disorder (N = 67).  This condensed the sample 
into attempters with Bipolar or Mood Disorder NOS only (N = 22) and attempters with 
Bipolar or Mood Disorder NOS and either a comorbid Disruptive or Substance Abuse 
Disorder (N = 45).  A dummy variable was created for attempters with comorbid Bipolar 
or Mood Disorder NOS and Disruptive or Substance Abuse Disorders, leaving attempters 
with Bipolar or Mood Disorder NOS only as the reference group.  Race analysis was not 
possible due to inadequate numbers for comparison.  No demographic or 
psychopathological comorbidity variables had a significant relationship with lethality in 
this model.  Table 10 summarizes the results of the Bipolar or Mood Disorder NOS 
comorbidity regression model. 
Table 10 
Multiple Regression on Lethality, with Psychopathological Comorbidity, for Subset of 
Attempters with Bipolar or Mood Disorder NOS (N = 67) 
Variable Lethality  
 β SE 
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Younger Age Group (N = 35) -0.29 0.35 
Male Gender (N = 11) 0.20 0.66 
Bipolar or Mood Disorder NOS and Disruptive or Substance Abuse (N = 45) 0.01 0.38 
F 0.37  
R2 0.01  
 
 Gender and lethality.  The next set of regression models tested the sixth 
hypothesis: 
H6:  Having a diagnosis of a Disruptive or Substance Abuse Disorder, in addition to a 
Depressive Disorder, has a stronger effect on suicide attempt lethality for adolescent 
females than adolescent males. 
Regression models were first run for each gender separately to examine what 
findings were statistically significant among each gender group.  Race groups were 
excluded due to inadequate numbers for comparison.  Assessment of coefficients showed 
no significant findings for the female or male group.  Table 11 summarizes the regression 
analysis for the female group, and Table 12 summarizes results for the male group. 
Table 11 
Multiple Regression on Lethality, with Psychopathological Comorbidity, for Female 
Gender Group, for Subset of Attempters with a Depressive Disorder (N = 155) 
Variable Lethality  
 β SE 
Younger Age Group (N = 99) 0.21 0.23 
Depressive and Disruptive or Substance Abuse (N = 46) 0.15 0.25 
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F 0.53  
R2 0.00  
 
Table 12 
Multiple Regression on Lethality, with Psychopathological Comorbidity, for Male 
Gender Group, for Subset of Attempters with a Depressive Disorder (N = 45) 
Variable  Lethality  
 β SE 
Younger Age Group (N = 99) -0.75 0.59 
Depressive and Disruptive or Substance Abuse (N = 17) -0.73 0.59 
F 2.23  
R2 0.07  
 
To test the sixth hypothesis using a different technique, interactions terms were 
made between gender and the comorbidity variable to determine if gender had a 
moderating effect on lethality.  Assessment of coefficients showed that females without 
comorbidity had significantly lower lethality than males (β = -0.87; p = 0.03).  Table 13 
summarizes the regression analysis with gender interaction effects. 
Table 13 
Multiple Regression on Lethality, with Psychopathological Comorbidity, with Gender 
Interaction Effects, for Subset of Attempters with a Depressive Disorder (N = 200) 
Variable  Lethality  
 β SE 
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Younger Age Group (N = 99) 0.00 0.22 
Female Gender -0.87* 0.39 
Depressive and Disruptive or Substance Abuse (N = 63) -0.80 0.59 
Female x Depressive and Disruptive or Substance Abuse (N = 46) 0.95 0.64 
F 1.22  
R2 0.03  
*Significant at the p<.05 level 
 
 Age group and lethality.  The next set of regression models tested the seventh 
hypothesis: 
H7:  Having a diagnosis of a Disruptive or Substance Abuse Disorder in addition to a 
Depressive Disorder has a stronger effect on suicide attempt lethality for younger 
adolescents than older adolescents. 
Regression models were run for each age group separately to examine what 
findings were statistically significant among each age group.  Race groups were excluded 
due to inadequate numbers for comparison.  No significant relationships were found in 
the regression analyses for the younger age group, which Table 14 summarizes. 
Table 14 
Multiple Regression on Lethality, with Psychopathological Comorbidity, for Younger 
Age Group, for Subset of Attempters with a Depressive Disorder (N = 99) 
Variable Lethality  
 β SE 
Male Gender (N = 24) -0.03 0.44 
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Depressive and Disruptive or Substance Abuse (N = 32) -0.02 0.35 
F 0.01  
R2 0.00  
 
For the older age group, male gender had a significant positive relationship with 
suicide attempt lethality (β = 1.06; p = 0.02).  Table 15 summarizes the regression 
analysis for the older age group. 
Table 15 
Multiple Regression on Lethality, with Psychopathological Comorbidity, for Older Age 
Group, for Subset of Attempters with a Depressive Disorder (N = 101) 
Variable  Lethality  
 β SE 
Male Gender (N = 21) 1.06* 0.45 
Depressive and Disruptive or Substance Abuse (N = 31) -0.10 0.33 
F 1.76  
R2 0.07  
*Significant at the p<.05 level 
To test the seventh hypothesis using a different technique, interactions terms were 
made between age group and the comorbidity variable to determine statistically 
significant differences between age groups.  Assessment of coefficients showed that 
males had higher lethality than females (β = 0.53; p = 0.09) at trend level, but did not 
support the hypothesis that age group had a moderating effect on lethality.  Table 16 
summarizes the regression analysis with age group interaction effects. 
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Table 16 
Multiple Regression on Lethality, with Psychopathological Comorbidity, with Age Group 
Interaction Effects, for Subset of Attempters with a Depressive Disorder (N = 200) 
Variable  Lethality  
 β SE 
Male Gender (N = 99) 0.53+ 0.31 
Younger Age Group -0.01 0.26 
Depressive and Disruptive or Substance Abuse (N = 63) -0.08 0.33 
Younger Age x Depressive and Disruptive or Substance Abuse (N = 32) 0.01 0.49 
F 0.72  
R2 0.02  
+Trend level significant at p<.10 
 
Summary of Hypothesis Testing 
H1:  Adolescents diagnosed with a Depressive Disorder do not make suicide attempts of 
higher lethality than adolescents without a Depressive Disorder. 
 Independent t-tests and OLS regression showed no significant relationship 
between Depressive Disorders and suicide attempt lethality.  Hypothesis supported. 
H2:  Adolescents diagnosed with a Disruptive Disorder do not make suicide attempts of 
higher lethality than adolescents without a Disruptive Disorder. 
 Independent t-tests and OLS regression showed no significant relationship 
between Disruptive Disorders and suicide attempt lethality.  Hypothesis supported. 
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H3:  Adolescents diagnosed with a Substance Abuse Disorder make suicide attempts of 
higher lethality than adolescents without a Substance Abuse Disorder. 
 Independent t-tests showed adolescent suicide attempters with a Substance Abuse 
diagnosis had higher lethality scores than attempters without the diagnosis (x¯  = 3.22; 
t(df=373) = -2.65; p = 0.008).  OLS regression showed that adolescent suicide attempters 
with a Substance Abuse diagnosis had higher lethality scores (β = 0.42; p = .02) than the 
rest of the sample.  Hypothesis supported. 
H4:  Adolescents diagnosed with a Disruptive or Substance Abuse Disorder, in addition 
to a Depressive Disorder, make suicide attempts of higher lethality than adolescents with 
a Depressive Disorder alone. 
 Bivariate analysis and OLS regression demonstrated no significant relationships 
between attempters with a Depressive and Disruptive or Substance Abuse Disorders and 
suicide attempt lethality.  Hypothesis not supported. 
H5:  Adolescents diagnosed with a Disruptive or Substance Abuse Disorder, in addition 
to Bipolar or Mood Disorder NOS, make suicide attempts of higher lethality than 
adolescents with Bipolar or Mood Disorder NOS alone. 
 Bivariate analyses showed attempters with comorbidity patterns of Bipolar or 
Mood Disorder NOS and Substance Abuse (x¯  = 3.37; t(df=373) = -2.14; p = 0.03) and 
Bipolar or Mood Disorder NOS and Disruptive and Substance Abuse (x¯  = 3.46; t(df=373) = 
-2.16; p = 0.03) had suicide attempts of higher lethality than those without those 
comorbidity patterns.  OLS regression showed no significant relationships between 
attempters with Bipolar or Mood Disorder NOS and Disruptive or Substance Abuse 
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Disorders and suicide attempt lethality.  Hypothesis supported by bivariate analysis; 
hypothesis not supported by multivariate analysis. 
H6:  Having a diagnosis of a Disruptive or Substance Abuse Disorder, in addition to a 
Depressive Disorder, has a stronger effect on suicide attempt lethality for adolescent 
females than adolescent males. 
 When comorbidity regression models were run separately for each gender for the 
subset of attempters with Depressive Disorders, no significant relationships with lethality 
were found for either the female or male group.  When interactions terms were made 
between gender and the comorbidity variable, assessment of coefficients showed that 
females without comorbidity had significantly lower lethality than males (β = -0.87; p = 
0.03).  Hypothesis not supported. 
H7:  Having a diagnosis of a Disruptive or Substance Abuse Disorder, in addition to a 
Depressive Disorder, has a stronger effect on suicide attempt lethality for younger 
adolescents than older adolescents. 
 OLS regression showed no significant differences in the relationship between 
comorbidity and suicide attempt lethality either within or between groups of younger and 
older adolescents.  Hypothesis not supported. 
 With respect to race findings, one-way ANOVA demonstrated no significant 
difference in lethality across race groups (F(df=5) = 0.97; p = 0.43).  However, ANOVA 
postestimation showed trend level differences between the African-American/Black and 
Caucasian/White groups, with African-American/Blacks having lower lethality than 
Caucasian/Whites (F(df=5) = 3.54; p = 0.06).  In OLS regression, African-American/Black 
race had a significant negative relationship with lethality in all psychopathology models 
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tested (β = -0.52; p = .03) when compared to Caucasian/White race.  Post-hoc tests for 
race demonstrated one trend level significant group difference between the African-
American/Black and Other race groups (F = 3.04; p = 0.07 for Model 1) in all models, 
with African-American/Blacks having significantly lower lethality than those in the Other 
race group. 
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CHAPTER IV 
 
Discussion 
 The primary aim of this study was to determine if various typologies of 
psychiatric diagnoses and patterns of comorbidity are differentially related to the medical 
lethality of adolescent suicide attempts.  The secondary aim was to determine if the 
relationship between psychopathological comorbidity and suicide attempt lethality is 
significantly different across gender, age, and race in the adolescent population.  Though 
not all hypotheses in this study were supported, those that were supported have important 
implications for adolescent suicide prevention programs, treatment of suicidal 
adolescents, and policies affecting adolescents at risk for suicide. 
Lethality and Psychopathological Comorbidity 
Depressive Disorders.  Having a Depressive Disorder was the most common 
psychopathological characteristic of this sample, as 74% (N = 272) of adolescent suicide 
attempters in this study carried the diagnosis.  This finding supports prior studies that 
posit depression may be the biggest diagnostic risk factor for adolescent suicide attempts 
(Fordwood et al., 2007; Kelly et al., 2001; Renaud et al., 2008).  However, depression 
alone did not predict suicide attempt lethality in either bivariate or multivariate results of 
this study, which also supports prior research findings (Wetzler et al., 1996).  This 
suggests that while a Depressive Disorder may be the most common diagnosis in 
adolescent suicide attempters, simply having the diagnosis does not distinguish medically 
serious suicide attempters from other less lethal attempters.  What was surprising in this 
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study was that Depressive Disorders and comorbid Disruptive or Substance Abuse 
Disorders were not found to be a unique predictor of suicide attempt lethality. 
This lack of support for this hypothesis contrasts previous research that suggests 
adolescents with either or both of these comorbidity patterns are more likely to have 
lethal attempts than those without (Brent, 1987; Nasser & Overholser, 1999; Portzky et 
al., 2005).  Possible reasons for this contrast in findings could be related to the 
differences in methodology and population among the studies.  Of all the studies that 
assessed for suicide attempt lethality, the only one to use the LSARS was the Nasser and 
Overholser (1999) study.  However, due to inadequate numbers this study had to separate 
out adolescents with suicide attempts of low (N = 20), medium (N = 20), and high (N = 
20) lethality.  Thus, they were only able to use bivariate analyses because the size of 
lethality groups was too small to conduct regression analyses.  The study by Portzky and 
colleagues (2005) was an autopsy study (N = 19) of small sample size that had no 
comparison group.  While the Brent (1987) study (N = 131) was a chart review, it was 
conducted 20 years ago, and the exact age of the child and adolescent subjects was 
unclear.  This study used the Risk Rescue Rating (RR) to measure suicide attempt 
lethality, and combined depression and bipolar together under the broader category of 
mood disorder, which also may explain some of the differences in results. 
The lack of significant findings for attempters with depressive disorders in this 
study suggests the importance of screening for symptoms other than depression in suicide 
prevention practices.  Many adolescent suicide prevention programs focus on the 
identification of depressive symptoms as the key to assessing suicide risk.  This is a 
fallacy, as depression alone does not predict which suicidal adolescents make lethal 
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suicide attempts (Wetzler et al., 1996), suggesting that there are other risk factors that 
distinguish suicide completers from attempters.  Suicide prevention programs that focus 
on the identification of depressive symptoms tend to overlook impulsivity and substance 
use as major contributing factors to lethal suicide attempts, and therefore may be missing 
a critical piece of the suicide risk assessment process. 
Bipolar Disorders.  Only 5% of the sample in this study had a Bipolar Disorder 
diagnosis, but when combined with Mood Disorder NOS, the total increased to just over 
one-fifth of the sample (N = 87).  Bivariate analysis showed attempters with comorbidity 
patterns of Bipolar or Mood Disorder NOS and Substance Abuse alone and Bipolar or 
Mood Disorder NOS and Disruptive and Substance Abuse had suicide attempts of higher 
lethality than attempters without those comorbidity patterns.  However, OLS regression 
showed no significant relationship between attempters with Bipolar or Mood Disorder 
NOS and Disruptive or Substance Abuse Disorders and suicide attempt lethality. 
The bivariate findings are supported by prior research by Beautrais (2003) which 
found child, adolescent, and young adult suicide completers to be significantly more 
likely to have a diagnosis of bipolar disorder than attempters.  However, these findings 
contrast those of Nasser and Overholser (1999) which found no significant differences in 
the medical lethality of suicide attempts of adolescents with bipolar disorders when 
compared to those with depressive disorders.  The lack of multivariate findings in this 
study could be related to the relatively small N of Bipolar and Mood Disorder NOS 
attempters used in OLS regression analysis.  It is also possible that combining these two 
diagnoses into the same category had an impact on the findings. 
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The bivariate results in this study have important implications for practice and 
future research with suicidal adolescents, as they suggest attempters with Bipolar or 
Mood Disorder NOS and either Substance Abuse alone or Substance Abuse and 
Disruptive Disorders are at greater risk for lethal suicide attempts when compared to 
attempters without those comorbidity patterns.  This finding suggests the importance of 
the role of impulsivity as a risk factor for medically serious suicide attempts.  Many 
adolescent suicide attempts are unplanned and made impulsively (Brown et al., 1991), 
and the inability to control aggressive impulses may even be a greater indicator of risk for 
impulsive suicide attempts than depression (Simon et al., 2001).  Because bipolar 
disorders have an impulsive characteristic distinct from depressive disorders (APA, 
2000), it is critical that practitioners take into account the role of impulsivity in assessing 
for adolescent suicide risk.  These findings further suggest the need for depressive and 
bipolar disorders to be considered separately in future adolescent suicide research, due to 
the inherent differences in symptomatology and varying implications with respect to risk 
factors.  These differences will be important to investigate in future studies as the 
knowledge base surrounding bipolar disorder is still underdeveloped and little is known 
about its relationship with adolescent suicidal behavior (Goldstein et al., 2005). 
Disruptive Disorders.  Just over one-third of the sample had a Disruptive Disorder 
(N = 135).  Depressive and Disruptive Disorder comorbidity did not demonstrate a 
significant relationship with lethality in either bivariate or multivariate analysis.  
However, when Disruptive Disorders were combined with Bipolar or Mood Disorder 
NOS and Substance Abuse, there was a significant positive relationship with lethality 
when compared to attempters without this comorbidity pattern in bivariate analysis only.  
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These results differ from the findings of the Nasser and Overholser (1999) study, which 
found comorbid depression and ADHD to be the only comorbidity pattern predictive of 
suicide attempts of high lethality. 
These contrasting findings from previous research warrant future study on 
comorbidity patterns with mood and disruptive disorders, and suggest that risk factors for 
lethal suicide attempts may differ depending on the specific typologies of mood and 
disruptive disorders that the adolescent carries as a diagnosis.  These results also 
reinforce the need for structured diagnostic interviews to be used in research on the 
relationship between psychopathology and suicide attempt lethality.  Some of the 
symptoms of disruptive and bipolar disorders are similar (APA, 2000), especially with 
respect to the impulsivity component of the disorders.  Therefore, future research using 
structured interviews to determine specific diagnostic criteria will be critical to enhancing 
our understanding of the role of psychopathology and comorbidity patterns in adolescent 
suicide risk assessment. 
Substance Abuse Disorders.  Slightly less than one-third of the sample had a 
Substance Abuse Disorder (N = 106), which was always comorbid with at least one other 
psychiatric diagnosis.  In both bivariate and multivariate analysis, investigating 
psychopathology without comorbidity patterns revealed that adolescents with a Substance 
Abuse Disorder made suicide attempts of higher lethality than attempters without the 
diagnosis.  This finding adds to the knowledge base surrounding the relationship between 
adolescent substance abuse and suicide attempts (Epstein & Spirito, 2009; Kelly, 
Cornelius, & Lynch, 2002; Wu et al., 2004) and suicide completion (Fleischmann et al., 
2005; Renaud et al., 2008).  In an older study by Brent, Perper, and Allman (1987) it was 
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estimated that nearly 50% of adolescent suicide completers may have been intoxicated at 
the time of their death.  This study further supports this link and in doing so continues to 
raise concern about substance abuse as a critical risk factor for suicide in adolescents. 
Although research on the impact of psychopathological comorbidity with 
substance abuse on adolescent suicide attempt lethality is sparse, prior studies do show a 
positive relationship between comorbid substance abuse and mood disorders and lethal 
suicide attempts (Brent, 1987) and suicide completion (Portzky et al., 2005).  When 
comorbidity was taken into account in this study, having both a Bipolar or Mood 
Disorder NOS diagnosis and a Substance Abuse Disorder was predictive of adolescent 
suicide attempts of higher lethality.  Interestingly, this relationship was not found for 
comorbidity with a Depressive Disorder.  This finding suggests that adolescents with a 
mood disorder with impulsive characteristics that have a comorbid substance abuse 
diagnosis may be at particularly high risk for a lethal suicide attempt when compared to 
suicidal adolescents with other diagnoses, and has important implications for suicide 
prevention practices.  Because this is an especially dangerous psychopathological 
combination for the suicidal adolescent, it is critical that suicide prevention screening 
programs assess for the presence of this specific comorbidity pattern.  The combination 
of the impulsivity inherent in certain mood disorders such as bipolar, and the impaired 
judgment caused by substance use, may amplify the risk for lethal suicide attempts in 
adolescents.  Assessing for this psychopathological profile in suicide risk screening tools 
will help to advance adolescent suicide prevention practices. 
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Lethality and Other Risk Factors 
Lethality and gender.  In this study, more females (N = 290) than males (N = 85) 
attempted suicide over a five year period.  The average mean for suicide attempt lethality 
was greater for males (x¯  = 3.04) than females (x¯  = 2.83) by a small amount, but this 
difference was not significant.  The frequency findings support prior epidemiological 
research which show that female adolescents attempt suicide more frequently than males 
(CDC, 2007), but the bivariate findings do not support prior research which suggests that 
suicide attempts of male adolescents are more likely to be fatal than those of females 
(CDC, 2007).  In light of recent statistics demonstrating an increase lethal suicide attempt 
methods by females of hanging, suffocation, and poisoning (CDC, 2007), this study 
posited that the more violent means of suicide attempts historically adopted by males and 
the more passive means of self-destruction utilized by females (Portes et al., 2002) may 
be changing.  Therefore, the gap in lethality of adolescent male and female suicide 
attempts would not be as large.  Bivariate findings of this study supported this 
proposition, as there was no significant relationship between gender and suicide attempt 
lethality.  However, in OLS regression, male gender was found to have a positive 
relationship with suicide attempt lethality at trend level (β = 0.53; p = .09) in the model 
testing the comorbidity pattern of Depressive and Disruptive or Substance Abuse 
Disorders.  Additionally, for the older age group regression model, male gender had a 
significant positive relationship with suicide attempt lethality (β = 1.06; p = 0.02).  This 
finding supports prior research that male adolescents are more likely than females to 
make lethal suicide attempts (CDC, 2007), and adds knowledge that being an older 
adolescent male may have an even greater impact on suicide attempt lethality than for 
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younger adolescent males, suggesting that gender differences may emerge later in 
adolescence. 
When comorbidity regression models were run separately for each gender for the 
subset of attempters with Depressive Disorders, no significant relationships with lethality 
were found for either the female or male group.  When interactions terms were made 
between gender and the comorbidity variable, assessment of coefficients showed that 
females without comorbidity had significantly lower lethality than males (β = -0.87; p = 
0.03).  This finding suggests the impact of the comorbid mood and disruptive or 
substance abuse disorders on suicide attempt lethality does not differ by gender.  While 
this specific relationship has not been investigated in prior studies, this finding is 
somewhat surprising in light of previous research suggesting that the presence of 
comorbidity has a larger impact on adolescent females than males with respect to the risk 
for suicide attempts (Brezo et al., 2007; Kelly et al, 2001; Wannan & Fombonne, 1998). 
Because disruptive and substance abuse disorders are more frequently identified 
in males than females (APA, 2000), it was speculated that because the risk factor of 
substance abuse and disruptive behaviors are not gender-normative for females, these 
comorbidity patterns would be indicative of more lethal suicide attempts in this 
population.  Prior research has indicated support for this hypothesis, as Brezo and 
colleagues (2007) found psychiatric comorbidity to have a significant effect on suicide 
attempts for females but not for males, and Kelly et al. (2001) found female adolescents 
with comorbid alcohol use and conduct disorders to be three times more likely to have 
attempted suicide than those with only one of those diagnoses.  In further contrast to the 
findings of this study, Wannan and Fombonne (1998) found depression to have 
63 
 
 
significant interaction effects with substance abuse and conduct disorders for females 
only.  One potential explanation for this result is that risk factors that are more prevalent 
in a particular gender group may actually be more likely to emerge as a pathway to lethal 
suicide attempts for that gender. 
Lethality and age.  Frequencies of suicide attempts by age group were almost 
equal in this study, as the younger groups accounted for 49% (N = 183) while the older 
group accounted for 51% (N = 192) of total attempts.  Due to the differences in cognitive 
capacities between younger and older adolescents, this study posited that younger 
adolescents are at greater risk than older adolescents for making a suicide attempt of high 
lethality that is unintentional.  Findings of this study did not support this hypothesis, and 
demonstrated no age group effects on suicide attempt lethality.  While this finding is not 
necessarily surprising, it does contrast the results of a study by Nrugham, Larsson, and 
Sund (2008) which found that having a depressive disorder predicts suicidal acts for older 
but not younger adolescents, suggesting that for younger adolescents there may be a 
profile of psychopathology other than depression that puts them at greater risk for a 
suicide attempt.  These contrasting results may be partially explained by the lack of 
specificity of the suicide attempt definition in the Nrugham et al. (2008) study, making it 
difficult to compare the two studies.  The lack of support for the age group hypothesis in 
this study suggests the need to learn more about how developmental issues can impact the 
lethality of adolescent suicide attempts, and to determine if there are any other 
developmental factors aside from biological age that play a role in this relationship. 
Lethality and race.  Caucasian/White was the predominant race group represented 
in the sample (N = 250), followed by Hispanic/Latino (N = 56), African-American/Black 
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(N = 36), and Other (N = 33).  Results from this study showed trend level differences in 
lethality between the African-American/Black and Caucasian/White groups, with 
African-American/Blacks having lower lethality than Caucasian/Whites (F(df=5) = 3.54; p 
= 0.06).  In OLS regression, African-American/Black race had a significant negative 
relationship with lethality in all psychopathology models tested (β = -0.52; p = .03) when 
compared to Caucasian/White race.  Post-hoc tests for race demonstrated one trend level 
significant group difference between the African-American/Black and Other race groups 
(F = 3.04; p = 0.07 for Model 1) in all models, with African-American/Blacks having 
significantly lower lethality than those in the Other race group. 
Overall, these findings suggest that being African-American/Black may be a 
protective factor for lethal suicide attempts in adolescents.  There is no prior research that 
examines the relationship between race and adolescent suicide attempt lethality.  
However, prior research is inconclusive surrounding race differences in rates of suicide 
attempts and completion.  Data over the years show that African-American/Black 
adolescents have lower rates of suicide completion than Caucasian/White adolescents 
(Wagner, 2009), but higher rates of suicide attempts than their Caucasian/White 
adolescent counterparts (CDC, 2007).  The results of this study appear to support prior 
research, as the lethality of suicide attempts by African-American/Black adolescents were 
significantly lower than that of other races, except Hispanic/Latino. 
One possible explanation for the lower rates of highly lethal suicide attempts and 
suicide completion by African-American/Blacks may be their potential differences from 
other races in their cultural beliefs surrounding suicide.  A recent study by Richardson-
Vejlgaard and colleagues (2009) on mood disordered Blacks, Whites, and Hispanics 
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found that Blacks reported the least accepting attitudes toward suicide.  This lack of 
suicide acceptance may be related to the finding of Walker, Lester, and Joe (2006) that 
Blacks are more likely to report the belief that God is responsible for life.  It can 
additionally be related to Maris’ (1969) statement that Blacks have typically coped with 
strain by turning to family, church, and community supports.  Knowing this we can 
postulate that being African-American/Black may be a protective factor for lethal suicide 
attempts in the adolescent population, but further research is needed to support this notion 
and to investigate the cultural processes surrounding this finding.  Further research in this 
area would be valuable as it can have important implications for the development of 
culturally appropriate interventions with suicidal adolescents. 
Implications 
 The findings of this study have important implications for adolescent suicide 
prevention programs, treatment of suicidal adolescents, and policies affecting adolescents 
at risk for suicide.  Results suggest that improvements in the assessment and treatment of 
substance abuse in suicidal adolescents can play a critical role in decreasing the 
adolescent suicide rates.  Substance abuse, when comorbid with any other disorder, was 
the only psychopathological predictor of adolescent suicide attempt lethality in this study.  
When comorbid with bipolar or mood disorder NOS, substance abuse had a significant 
positive relationship with lethality in bivariate analyses, demonstrating the importance of 
identifying and treating substance abuse in suicidal adolescents.  In order to further 
develop prevention and treatment strategies with this population, policies must be 
initiated that will support their advancement. 
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 Suicide prevention.  The findings of this study have important implications for 
suicide prevention practices.  Depression alone was not found to be a significant predictor 
of suicide attempt lethality in this study, suggesting that screening for symptoms other 
than depression is critical to effective suicide prevention in the adolescent population.  As 
other studies have suggested, a comprehensive suicide prevention strategy with youth 
should target mental health concerns as a whole, not just depression alone (Fleischmann 
et al., 2005).  Because substance abuse is a critical indicator of suicide attempt lethality, 
substance use should be routinely assessed in suicide screening tools, and should be 
viewed as an important factor when determining suicide risk. 
Similarly, study results demonstrate the need for advancement of suicide risk 
assessments for adolescents that are receiving substance abuse treatment.  Depressive 
symptoms may often be overlooked when treating a substance abusing adolescent, as the 
use of substances can often mask the symptoms.  Additionally, adolescents withdrawing 
from substances may be at heightened risk for suicide, even those without a comorbid 
mood disorder diagnosis.  This implication extends to suicide risk assessment strategies 
in juvenile detention facilities, as many adolescents in those institutions have significant 
substance abuse issues.  The assessment and treatment of comorbid mood disorders are 
often overlooked in such facilities, leaving a potentially high-risk population in danger of 
making unpredicted lethal suicide attempts. 
Treatment.  The findings of this study also have important implications for the 
treatment of suicidal adolescents with comorbid substance abuse disorders.  Primarily, 
the results suggest the need for further development and implementation of dual 
diagnosis (comorbid psychiatric and substance abuse disorders) treatment strategies with 
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this population.  While many dual diagnosis treatment programs exist for adults, for 
adolescents they are sparse.  Part of the reason for this is that suicidal adolescents with 
comorbid substance abuse problems can be especially challenging for clinicians because 
of their multiple treatment needs (Goldston, Curry, Wells, & Roley, 2011).  There is 
often debate about which disorder to treat first with adolescents with comorbid mood and 
substance abuse disorders (Hawkins, 2009).  Adolescent substance abuse treatment 
research emphasizes the importance of implementing integrated services (Esposito-
Smythers & Goldston, 2008; Hawkins, 2009) rather than conducting serial or parallel 
treatment for comorbid substance abuse and psychiatric disorders (Hawkins, 2009).  The 
findings of this study emphasize the importance of ending the historical separation of the 
fields of mental health and substance abuse, and suggest that in adolescents with such 
comorbidity patterns, both disorders should be treated as primary (Hawkins, 2009). 
 Policy.  This study also has important implications for policies affecting the 
suicidal adolescent.  Overall, the findings of this study support others that suggest the 
need to promote parity for mental health and substance abuse services and advocate for 
government funding of mental health services (Hawkins, 2009).  Current service systems 
are generally inadequately prepared to meet adolescent substance abuse treatment needs 
because of multiple clinical, administrative, financial, and policy barriers (Hawkins, 
2009), and because the average cost of treating youth with comorbid disorders is more 
than double what it costs to treat an adolescent with just one disorder (King, Gaines, 
Lambert, Summerfelt, & Bickman, 2000).  Findings from this study suggest the need for 
the development of more cost-effective treatment techniques for suicidal adolescents with 
comorbid substance abuse issues.  As suggested by Hawkins (2009), creative and flexible 
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financing strategies need to be implemented to overcome these obstacles in order to 
support the development of integrated treatment systems.  Policies in support of 
prevention strategies and treatment programs for this population are necessary to make 
these advancements. 
Limitations 
There are some methodological limitations in this study, suggesting a cautious 
interpretation of the results.  Specifically, there were some issues with measurement that 
are important to address.  First, it was not possible to use structured interviews to 
determine psychiatric diagnoses.  Instead, diagnoses had already been made by CHB 
psychiatric clinicians following interviews with the patient, family members, and other 
collateral contacts.  Even though this study was able to account for documented histories 
of disruptive and substance abuse disorders in an effort to correct for comorbid diagnoses 
being under-recognized (Nasser & Overholser, 1999), the lack of structured interviews to 
determine diagnoses contributed to a level of subjectivity in the measurement of 
psychopathology variables in this study.  The second measurement limitation relates to 
the LSARS-II.  It is unclear if the LSARS-II has been tested for cross-cultural 
equivalence or requires updates to include more scenarios with adolescents.  Therefore, it 
would be helpful to test the measure with focus groups of clinicians that work with 
suicidal adolescents to determine if further revisions are necessary. 
This study had one limitation with respect to the sample; there were 13 repeat 
attempters.  These 13 repeat attempters were not dropped from the study because the 
psychopathological profile of attempters can look different across time and because it 
could not be determined if any of the other attempters in the study had multiple suicide 
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attempts which were previously treated at different hospitals.  Another limitation was that 
the subset of attempters with Bipolar or Mood Disorder NOS was not large enough to 
examine gender differences.  This was unfortunate as bivariate tests demonstrated a 
significant relationship between these comorbidity patterns and suicide attempt lethality.  
Similarly, while bivariate tests investigated race differences in lethality, analyses were 
still somewhat limited as the sample size for all races other than Caucasian/White was not 
large enough to make more advanced multivariate statistical comparisons with respect to 
psychopathological comorbidity.  An additional limitation was that SES could not be 
collected in this study.  Finally, it was not possible to examine other psychosocial risk 
factors for suicide attempts of high lethality and suicide completion in adolescents such 
as precipitating events (Beautrais, 2003), prior suicidal acts (Renaud et al., 2008), and 
suicidal intent (Nasser & Overholser, 1999), therefore limiting the explanatory power of 
the regression models in this study. 
Future Research 
 The findings from this study have some important implications for future research 
with adolescent suicide attempters.  First, depressive and bipolar disorders should not be 
combined into the same mood disorder category, due to the inherent differences in 
symptomatology and varying implications with respect to risk factors for suicide.  Many 
prior studies on adolescent suicide attempts have excluded subjects with bipolar 
diagnoses either because they were examining comorbidity with depression alone or 
because the sample size of bipolar subjects was not large enough to draw conclusions 
about the population.  By ignoring this difference in construct we are missing important 
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knowledge about the interplay between specific psychopathological and demographic 
risk factors in predicting the lethality of adolescent suicide attempts. 
Future studies on adolescent suicide attempters should use structured diagnostic 
interviews to measure psychopathology variables, as determining diagnostic criteria can 
be subjective unless an instrument with good psychometric properties is used.  Similarly, 
it is important that future studies use instruments that measure the nature of the substance 
abuse and the types of substances used, to see if they have differing effects on suicide 
attempt lethality, as prior studies have shown some substances to be more predictive of 
attempted suicide than others (Kelly et al., 2002).  For instance, alcohol is a very 
concerning substance of abuse in the adolescent population with respect to its relationship 
with suicide attempts.  Possible reasons for this are that alcohol can be disinhibiting and 
can lead to more impulsive suicide attempts, and many adolescents attempt suicide after 
consuming alcohol as a way to cope with a stressful life event.  Additionally, alcohol is 
the least expensive and most easily accessible substance, often making it the substance of 
choice among adolescents.  Therefore, it would be beneficial for future studies to 
specifically examine alcohol abuse diagnoses, in comparison to other substance abuse 
diagnoses, as a predictor of suicide attempt lethality in the adolescent population. 
Because the results of this study suggest that adolescents with a substance abuse 
diagnosis may be at greatest risk for lethal suicide attempts, research involving the 
development of treatment strategies should focus on this subset of the adolescent 
population (Esposito-Smythers & Goldston, 2008).  Despite the strong association 
between adolescent substance use and suicidal behaviors, few studies have investigated 
the effectiveness of combined treatment of these two problems (Conason, Oquendo, & 
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Sher, 2006).  While it is argued that integrated treatment strategies for this population are 
critical, research in this area is lacking (Goldston et al., 2011).  Especially little is known 
about treatment for adolescents with comorbid bipolar and substance abuse disorders.  
Because the diagnosis of bipolar disorder typically precedes substance use among youth, 
there may be a window of opportunity for screening and prevention of substance use with 
this population (Goldstein & Bukstein, 2010). 
It is also recommended that future studies on adolescent suicide attempters follow 
youth longitudinally, to determine if the lethality of attempts change over time.  
Unfortunately, this study did not have enough repeat attempters to examine these 
patterns.  It would also be helpful in future studies to examine substance use 
longitudinally, and to determine the temporal relationship between suicidal ideation, 
suicide attempts, and substance abuse in the adolescent population.  Additionally, in 
order to generate a more explanatory model of adolescent suicidal behavior, it will be 
critical that future research investigates the influence of other psychosocial factors. 
Findings of this study suggest the importance of future research on the role gender 
differences in adolescent suicidal behaviors.  While a significant relationship between 
Depressive Disorder comorbidity patterns and suicide attempt lethality did not emerge for 
females in this study, it is important to recognize that the subset of attempters with 
Bipolar or Mood Disorder NOS was not large enough to make gender comparisons.  
Because Bipolar or Mood Disorder NOS comorbidity patterns did demonstrate a 
significant positive relationship with lethality in the bivariate analysis of this study, we 
can postulate that having this type of comorbidity pattern may have a positive 
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relationship with lethality for females.  However, more research needs to be done with 
larger sample sizes to garner support for this proposition. 
It is additionally critical to recognize that much of the prior research in this area 
was conducted over 10 years ago, and it is likely that in the past 10 years there have been 
significant shifts in gender-normative behaviors.  Therefore, the lack of significant 
findings with respect to comorbidity with Depressive Disorders in females in this study 
may be better understood in the changing socio-behavioral context of the past decade.  
Further research needs to be conducted to determine if this emerges as a more consistent 
gender pattern among adolescent suicide attempters.  Similarly, it is recommended that 
whenever possible, sample sizes need to be large enough to compare results across race 
groups so that we can better understand if certain races serve as risk of protective factors 
for medically serious suicide attempts. 
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CHAPTER V 
 
Summary 
Purpose and Aims 
 The primary aim of this study was to determine if various typologies of 
psychiatric diagnoses and patterns of comorbidity are differentially related to the medical 
lethality of adolescent suicide attempts.  The secondary aim was to determine if the 
relationship between psychopathological comorbidity and suicide attempt lethality is 
significantly different across gender, age, and race in the adolescent population.  Specific 
hypotheses and findings included: 
H1:  Adolescents diagnosed with a Depressive Disorder do not make suicide attempts of 
higher lethality than adolescents without a Depressive Disorder. 
 Independent t-tests and OLS regression showed no significant relationship 
between Depressive Disorders and suicide attempt lethality.  Hypothesis supported. 
H2:  Adolescents diagnosed with a Disruptive Disorder do not make suicide attempts of 
higher lethality than adolescents without a Disruptive Disorder. 
 Independent t-tests and OLS regression showed no significant relationship 
between Disruptive Disorders and suicide attempt lethality.  Hypothesis supported. 
H3:  Adolescents diagnosed with a Substance Abuse Disorder make suicide attempts of 
higher lethality than adolescents without a Substance Abuse Disorder. 
 Independent t-tests showed adolescent suicide attempters with a Substance Abuse 
diagnosis had higher lethality scores than attempters without the diagnosis (x¯  = 3.22; 
t(df=373) = -2.65; p = 0.008).  OLS regression showed that adolescent suicide attempters 
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with a Substance Abuse diagnosis had higher lethality scores (β = 0.42; p = .02) than the 
rest of the sample.  Hypothesis supported. 
H4:  Adolescents diagnosed with a Disruptive or Substance Abuse Disorder, in addition 
to a Depressive Disorder, make suicide attempts of higher lethality than adolescents with 
a Depressive Disorder alone. 
 Bivariate analysis and OLS regression demonstrated no significant relationships 
between attempters with a Depressive and Disruptive or Substance Abuse Disorders and 
suicide attempt lethality.  Hypothesis not supported. 
H5:  Adolescents diagnosed with a Disruptive or Substance Abuse Disorder, in addition 
to Bipolar or Mood Disorder NOS, make suicide attempts of higher lethality than 
adolescents with Bipolar or Mood Disorder NOS alone. 
 Bivariate analyses showed attempters with comorbidity patterns of Bipolar or 
Mood Disorder NOS and Substance Abuse (x¯  = 3.37; t(df=373) = -2.14; p = 0.03) and 
Bipolar or Mood Disorder NOS and Disruptive and Substance Abuse (x¯  = 3.46; t(df=373) = 
-2.16; p = 0.03) had suicide attempts of higher lethality than those without those 
comorbidity patterns.  OLS regression showed no significant relationships between 
attempters with Bipolar or Mood Disorder NOS and Disruptive or Substance Abuse 
Disorders and suicide attempt lethality.  Hypothesis supported by bivariate analysis; 
hypothesis not supported by multivariate analysis. 
H6:  Having a diagnosis of a Disruptive or Substance Abuse Disorder, in addition to a 
Depressive Disorder, has a stronger effect on suicide attempt lethality for adolescent 
females than adolescent males. 
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 When comorbidity regression models were run separately for each gender for the 
subset of attempters with Depressive Disorders, no significant relationships with lethality 
were found for either the female or male group.  When interactions terms were made 
between gender and the comorbidity variable, assessment of coefficients showed that 
females without comorbidity had significantly lower lethality than males (β = -0.87; p = 
0.03).  Hypothesis not supported. 
H7:  Having a diagnosis of a Disruptive or Substance Abuse Disorder, in addition to a 
Depressive Disorder, has a stronger effect on suicide attempt lethality for younger 
adolescents than older adolescents. 
 OLS regression showed no significant differences in the relationship between 
comorbidity and suicide attempt lethality either within or between groups of younger and 
older adolescents.  Hypothesis not supported. 
 Race was also investigated for a potential relationship with suicide attempt 
lethality.  African-American/Black race had a significant negative relationship with 
lethality in all psychopathology models tested compared to Caucasian/White and Other 
race. 
Methodology 
Psychiatric evaluations were reviewed for all adolescents that presented to 
Children’s Hospital Boston (CHB) from 2006 to 2010 for a suicide attempt (N = 375).  
The Lethality of Suicide Attempt Rating Scale II (LSARS-II) was used to measure the 
dependent variable of lethality (Berman, Shepherd, & Silverman, 2003).  
Psychopathological comorbidity was measured using DSM-IV-TR diagnoses from the 
psychiatric evaluations.  The first step of the data analysis process included a descriptive 
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analysis of each of the variables via frequency distributions.  Second, bivariate tests were 
used to determine if statistically significant relationships existed between each of the 
independent variables and the dependent variable of suicide attempt lethality.  Third, 
OLS regression was used to determine the percent of variance in the dependent variable 
explained by the independent variables and to rank the relative importance of the 
independents.  Additionally, moderating effects were examined by creating interaction 
terms for gender and psychopathological comorbidity, as well as age group and 
psychopathological comorbidity. 
Results 
Bivariate results showed that attempters diagnosed with a Substance Abuse 
Disorder had higher levels of suicide attempt lethality than those without the diagnosis.  
Additionally, having Bipolar or Mood Disorder NOS in combination with either 
Substance Abuse alone or Substance Abuse and Disruptive Disorders had a significant 
positive relationship with suicide attempt lethality when compared to attempters without 
those comorbidity patterns.  In OLS regression, Substance Abuse was the only significant 
diagnostic predictor of lethality, and no psychopathological comorbidity patterns were 
predictive of lethality.  Male gender was found to have a positive relationship with 
suicide attempt lethality at trend level in the model testing the comorbidity pattern of 
Depressive and Disruptive or Substance Abuse Disorders.  Additionally, for the older age 
group regression model, male gender had a significant positive relationship with suicide 
attempt lethality.  When comorbidity regression models were run separately for each 
gender for the subset of attempters with Depressive Disorders, no significant 
relationships with lethality were found for either the female or male group.  When 
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interactions terms were made between gender and the comorbidity variable, assessment 
of coefficients showed that females without comorbidity had significantly lower lethality 
than males.  OLS regression showed no significant differences in the relationship 
between comorbidity and suicide attempt lethality either within or between groups of 
younger and older adolescents.  ANOVA postestimation showed trend level differences 
between the African-American/Black and Caucasian/White groups, with African-
American/Blacks having lower lethality than Caucasian/Whites.  In OLS regression, 
African-American/Black race had a significant negative relationship with lethality in all 
psychopathology models tested when compared to Caucasian/White race.  Post-hoc tests 
for race demonstrated one trend level significant group difference between the African-
American/Black and Other race groups in all models, with African-American/Blacks 
having significantly lower lethality than those in the Other race group. 
Implications 
While having a Depressive Disorder was the most common psychopathological 
characteristic of this sample, this diagnosis alone did not predict suicide attempt lethality 
in either bivariate or multivariate analysis, suggesting that having a Depressive Disorder 
alone does not distinguish medically serious suicide attempters from other less lethal 
attempters.  However, having a Substance Abuse Disorder was a unique 
psychopathological predictor of adolescent suicide attempt lethality, suggesting the 
importance of the identification and treatment of substance abuse in suicidal adolescents.  
Additionally, having Bipolar or Mood Disorder NOS in combination with either 
Substance Abuse alone or Substance Abuse and Disruptive Disorders had a significant 
positive relationship with suicide attempt lethality when compared to attempters without 
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those comorbidity patterns, demonstrating the critical role of impulsivity as a risk factor 
for medically serious suicide attempts. 
The findings of this study have important implications for adolescent suicide 
prevention programs, treatment of suicidal adolescents, and policies affecting adolescents 
at risk for suicide.  Results suggest that improvements in the assessment and treatment of 
substance abuse in suicidal adolescents can play a critical role in decreasing the 
adolescent suicide rates.  Substance abuse disorder was the only unique 
psychopathological predictor of adolescent suicide attempt lethality in this study, and its 
comorbidity with bipolar or mood disorder NOS had a significant positive relationship 
with lethality in bivariate analyses, demonstrating the importance of identifying and 
treating substance abuse in suicidal adolescents, especially those with an impulsive type 
of mood disorder.  In order to further develop prevention and treatment strategies with 
this population, policies must be initiated that will support their advancement. 
Future research with suicidal adolescents needs to focus on the development of 
effective treatment strategies with suicidal adolescent substance abusers, and aim for a 
better understanding of suicidal behaviors of adolescents with comorbid bipolar and 
substance abuse diagnoses.  For future studies of this nature to be effective, mood and 
substance abuse disorders should be broken down into specific typologies.  Gender and 
race differences must also be investigated whenever possible in future research with 
adolescent suicide attempters. 
In sum, the findings of this study demonstrate the importance of substance abuse 
as a risk factor for lethal adolescent suicide attempts.  Future practice, policy, and 
research efforts with suicidal adolescents should aim to improve the assessment and 
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treatment of comorbid substance abuse in suicidal adolescents.  By doing so, important 
steps can be taken towards decreasing the adolescent suicide rate. 
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APPENDIX A 
 
Lethality of Suicide Attempt Rating Scale-Updated.  Adapted from Berman, Shepherd, & 
Silverman (2003) and Smith, Conroy, & Ehler (1984). 
 
Definition of Scale Points: 
 
0.0  DEATH IS AN IMPOSSIBLE RESULT OF THE “SUICIDAL” BEHAVIOR. 
 
Cutting:  Light scratches that do not break the skin: usually done with pop can “pull tabs,” broken 
plastic, pins, paper clips; reopening old wounds also is included at this level.  Wounds requiring 
sutures must be rated at higher level. 
Ingestion:  This includes mild overdoses and the swallowing of objects such as money, paper 
clips, and disposable thermometers.  Examples:  Ten or fewer ASA, Tylenol®, “cold pills,” 
laxatives, or other over-the-counter drugs; mild doses of tranquilizers or prescribed medications 
(usually fewer than 10 pills).  Putting broken glass into one’s mouth but not swallowing would be 
rated in this category. 
Other:  Clearly ineffective acts which are usually shown by the patient to staff or others (e.g., 
going outside in cold weather with only a nightgown on after telling parents she was going to 
commit suicide by “freezing myself to death”). 
 
1.0  DEATH IS VERY HIGHLY IMPROBABLE.  IF IT OCCURS IT WOULD BE A RESULT 
OF A SECONDARY COMPLICATION, AN ACCIDENT, OR HIGHLY UNUSUAL 
CIRCUMSTANCES. 
 
Cutting:  Shallow cuts without tendon, nerve, or vessel damage.  These wounds may require some 
minor suturing.  Cutting is often done with something sharp such as a razor.  Very little blood 
loss.  Scratches (as opposed to cuts) to the neck are first rated in this category. 
Ingestion:  Relatively mild overdoses or swallowing of non-sharp glass or ceramics, events 
usually brought by the parents to staff attention.  Examples:  Twenty or fewer ASA, laxatives, 
and/or over-the-counter drugs; mild doses of tranquilizers or prescribed medications (e.g., 15 or 
fewer Tylenol®).  Small doses of potentially lethal medications. 
Other:  Tying a thread, string, or yarn around neck and then showing it to staff. 
 
2.0  DEATH IS IMPROBABLE AS AN OUTCOME OF THE ACT: IF IT OCCURS IT IS 
PROBABLY DUE TO UNFORESEEN SECONDARY EFFECTS.  FREQUENTLY THE ACT 
IS DONE IN A PUBLIC SETTING OR IS REPORTED BY THE PERSON OR BY OTHERS.  
WHILE MEDICAL AID MAY BE WARRANTED, IT IS NOT REQUIRED FOR SURVIVAL. 
 
Cutting:  May receive but does not usually require medical intervention to survive.  Examples:  
Relatively superficial cuts with a sharp instrument that may involve slight tendon damage.  Cuts 
to the arms, legs, and wrists will require suturing.  Cuts to the side of the neck are first rated in 
this category and should not require suturing. 
Ingestion:  May receive but does not usually require medical intervention to survive.  Examples:  
Thirty or fewer ASA and/or over-the-counter pills; fewer than 100 laxatives, 25 or fewer 
Tylenol®; drinking of toxic liquids (12 ounces or less), shampoo or astringent, lighter fluid or 
other petroleum-based product (less than 2 ounces).  Small doses of potentially lethal 
medications, greater quantities might be taken when staff is notified within minutes by the 
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patient.  14 or fewer Lithium carbonate tablets.  Patient may swallow small quantities of cleaning 
compounds or fluids such as Comet® (less than 4 tablespoons). 
Other:  Non-lethal usually impulsive and ineffective methods.  Examples:  Inhaling deodorant 
without respiratory distress occurring, swallowing several pieces of sharp glass, evidence of 
failed attempt to choke self with a pillowcase (e.g., rash-type abrasions). 
 
3.5  DEATH IS IMPROBABLE SO LONG AS FIRST AID IS ADMINISTERED BY A 
VICTIM OR OTHER AGENT.  VICTIM USUALLY MAKES A COMMUNICATION OR 
COMMITS THE ACT IN A PUBLIC WAY OR TAKES NO MEAURES TO HIDE SELF OR 
INJURY. 
 
Cutting:  Deep cuts involving tendon damage (or severing) and possible nerve, vessel, and artery 
damage; cuts to the neck will require sutures but no major vessels were severed.  Blood loss is 
generally less than 100cc.  Cuts to neck go beyond scratching but do not actually sever main 
veins or arteries. 
Ingestion:  This is a significant overdose.  Examples:  Sixty or fewer ASA and/or over-the-
counter pills; over 100 laxatives, 50 or fewer Tylenol®.  Potentially lethal overdoses (e.g., 60 
Dilantin plus half a fifth of rum) but done in such a way as to ensure intervention (e.g., in front of 
nursing staff, telling someone within one hour). Signs of psychological distress may be present 
such as nausea, elevated blood pressure, respiratory changes, convulsions, and altered 
consciousness stopping short of a coma.  Lighter fluid (3 or more ounces); 15-20 Lithium 
carbonate tablets. 
Other:  Possibly serious actions that are quickly brought by the patient to staff’s attention (e.g., 
tied a shoelace tightly around neck but came to staff immediately). 
 
5.0  DEATH IS A FIFTY-FIFTY PROBABILITY DIRECTLY OR INDIRECTLY, OR IN THE 
OPINION OF THE AVERAGE PERSON, THE CHOSEN METHOD HAS AN EQUIVOCAL 
OUTCOME.  USE THIS RATING ONLY WHEN: 1)DETAILS ARE VAGUE; 2)A CASE 
CANNOT BE MADE FOR RATING EITHER A 3.5 OR 7.0. 
 
Cutting:  Severe cutting resulting in sizeable blood loss (more than 100cc) with some chance of 
death.  Cutting may be accompanied by alcohol or drugs, which may cloud the issue. 
Ingestion:  Reports of vague but possibly significant quantities of lethal medications.  Unknown 
quantities of drugs that are lethal in small dosages also belong here.  Examples:  Took 60 ASA 
and an undetermined amount of other medications. 
Other:  Potentially lethal acts.  Examples:  Trying to put two bare wires into an electrical outlet 
with a nurse present in the room; jumping headfirst from a car driven by staff going 30 miles an 
hour; unscrewing a light bulb in the lounge and putting finger in socket with patients around. 
 
7.0  DEATH IS THE PROBABLE OUTCOME UNLESS THERE IS “IMMEDIATE” AND 
“VIGOROUS” FIRST AID OR MEDICAL ATTENTION BY VICTIM OR OTHER AGENT.  
ONE OR BOTH OF THE FOLLOWING ARE ALSO TRUE: 1)MAKES COMMUNICATION 
(DIRECTLY OR INDIRECTLY); 2)PERFORMS ACT IN PUBLIC WHERE HE IS LIKELY 
TO BE HELPED OR DISCOVERED. 
 
Cutting:  Cuts are severe.  Examples:  Eloping and “slashing neck with razor” (including severing 
jugular) but returning to hospital on own and asking for help; while alone cut head with shard of 
glass and “almost bled to death” – called doctor after cutting.  Eloping and very severely cutting 
self in a public restroom or motel – cuts led to hemorrhagic shock with vascular collapse – patient 
makes direct request for help after cutting. 
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Ingestion:  Potentially lethal medications and quantities.  This would involve a dose which, 
without medical intervention, would kill most people.  Examples:  Eloping and ingesting 
approximately 2 bottles of ASA and then returning to the hospital; 50 Extra-Strength of 
Tylenol®, eloping to motel and ingesting large quantities of Inderal, Dalmane, Mellaril, and three 
quarters of a fifth of bourbon, then making indirect communication of distress; took 23 100mg 
tablets of Phenobarbital but told roommate immediately who told staff; 16-18 capsules of 
Nembutal – left note with friend who missed the note resulting in the patient almost dying. 
Other:  Lethal actions performed in a way that maximizes chances of intervention.  Examples:  
Tied towel tightly around neck – airway cut off – tried to untie it but passed out on floor – found 
cyanotic and in respiratory arrest – had seen staff making rounds before attempt; string wrapped 
several times around neck and tied to bed – face flushed when found. 
 
8.0  DEATH WOULD ORDINARILY BE CONSIDERED THE OUTCOME TO THE 
SUICIDAL ACT, UNLESS SAVED BY ANOTHER AGENT IN A “CALCULATED” RISK 
(e.g., NURSING ROUNDS OR EXPECTING A ROOMMATE OR SPOUSE AT A CERTAIN 
TIME).  ONE OR BOTH OF THE FOLLOWING ARE TRUE: 1)MAKES NO DIRECT 
COMMUNICATION; 2)TAKES ACTION IN PRIVATE. 
 
Cutting:  Severe gashes with major and quick blood loss.  May be partially hidden from staff, 
spouse, or friends.  Examples:  Patient went into bathroom of his room, left the door open and 
severely cut one wrist resulting in major blood loss; death would have occurred had he not been 
found 30 minutes later by nursing staff on rounds. 
Ingestion:  Clearly lethal doses and no communication is made.  Examples:  Taking a lethal 
overdose of barbituates but vomiting before going into a coma; overdosed on 900mg Stelazine in 
apartment alone; overdosed on Phenobarbital plus alcohol, found comatose in her bed.  Took 20 
Tuinal and became very sleepy while visiting friends – the friends became suspicious and took 
her to emergency room – in coma for 36 hours; took 15 Tuinal – found unconscious at home in 
tub of warm water. 
Other:  Most common here are hangings and suffocations which may or may not succeed but are 
performed so that a calculated chance of intervention could interrupt.  Examples:  Tying belt very 
tightly around neck and strangling self in shower; tied shoelace lightly around neck and going to 
bed – found at rounds to be cyanotic; blocked airways with plastic and had tied a stocking tightly 
around neck – found on top of bed gurgling and pale but not cyanotic; elopes and attempts to 
drown self in nearby pond but in broad daylight; jumps in front of fast-moving car (over 30 mph); 
plastic bag over head – found deeply cyanotic; played Russian roulette and drew a “pass.” 
 
9.0  DEATH IS A HIGHLY PROBABLE OUTCOME; “CHANCE” INTERVENTION AND/OR 
UNFORESEEN CIRCUMSTANCES MAY SAVE VICTIM.  TWO OF THE FOLLOWING 
CONDITIONS ALSO EXIST: 1) NO COMMUNICATION IS MADE; 2)EFFORT IS PUT 
FORTH TO OBSCURE ACT FROM HELPERS’ ATTENTION; 3)PRECAUTIONS AGAINST 
BEING FOUND ARE INSTUITUTED (e.g., ELOPING). 
 
Cutting:  Severe, usually multiple cuts involving severe blood loss.  Examples:  Severely cutting 
arm with razor and bleeding into wastebasket then got into bed (it was bedtime so being in bed 
did not arouse suspicion) – found unconscious and in shock; savagely biting a 2 cm piece of skin 
out of wrist, losing 4 pints of blood and found in shock under bed covers; cut neck in arts and 
crafts bathroom (when shop was closed) with three-inch blade, found unconscious; severely cut 
throat with broken bottle in unit shower – this was done when most patients were away from the 
unit – difficulty breathing when found; cut neck and wrist in bathtub at home – died by drowning 
– had “hoped” husband would happen by to discover. 
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Ingestion:  Clearly lethal doses.  Examples:  Drinking several ounces of nail polish remover – 
found covered in bed gagging, pale with large amount of foaming exudate coming from mouth – 
mildly comatose; took 30 500mg Doriden tablets right before bedtime – in bed, appeared to be 
asleep but was actually unconscious in a deep coma. 
Other:  Highly lethal means employed.  Examples:  Plastic bag tied tightly over head with a scarf 
– found unconscious with head in toilet; drove head on into a gasoline truck but survived with 
minor scratches and bruises; stuffed plastic in both nostrils and oral pharynx, completely closing 
airways – she appeared to be sleeping in bed under covers; eloped to another city in car, tied 
plastic hose to exhaust and suffocated in parking lot; hanged self in closet with door closed – not 
breathing when cut down’ jumped from 90 foot bridge into water – was unconscious when found.  
Gunshot to chest area (if shotgun used, rate 10.0); jumped headfirst from three-story building. 
 
10.0  DEATH IS ALMOST A CERTAINTY REGARDLESS OF THE CIRCUMSTAMCES OR 
INTERVENTIONS BY AN OUTSIDE AGENT.  MOST OF THE PEOPLE AT THIS LEVEL 
DIE QUICKLY AFTER THE ATTEMPT.  A VERY FEW SURVIVE THROUGH NO FAULT 
OF THEIR OWN. 
 
Cutting:  Just cuts as severe as 9.0, except that the likelihood for intervention is even more 
remote.  Blood loss is severe and quick.  Examples:  Eloping to empty house and severely cutting 
wrists and neck with razor – when a policeman happened by the patient was sitting in a large pool 
of blood, warded off the policeman with the razor. 
Ingestion:  Because of the time usually involved before a toxin can take effect there are very few 
instances of overdosing that can be considered this serious.  Examples:  Ingesting furniture polish, 
paint thinner, and many prescription medications while alone in the house with no one expected 
by; overdose on large quantities of Dalmane and barbituates with husband out of town and no 
children or other live-in companions in the household; ingested 60 Nembutal, went into secluded, 
wooded area in mid-winter, covered self with leaves which caused him not to be found for several 
days. 
Other:  These are the most common types of attempts at this level.  Examples:  Jumping off a tall 
building (four or more floors); jumping in front of cars on a freeway and being hit; eloping and 
hanging self in gym locker building at night; secretly eloping and drowning self in lake at a time 
when there was no activity in lake area and when he would not be expected to be on the unit; 
gunshot to the head and any effort involving a shotgun.
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Scoring codes: Number of tablets or  
ounces required to produce life threatening 
effects for medications. Nonmedicinal 
chemicals will be based on signal word from 
labels for pesticides and household products.  
 
 
Med amounts Signal word 
I <10 Danger <50mg/kg 
II 10 to 20 Warning 50-250mg/kg 
III 21 to 30 Warning 251-500mg/kg 
IV 31 to 60 Caution 501-2500mg/kg 
V 61 to 100 Caution 2501-5000mg/kg 
VI >100 None >5000mg/kg 
 
Patient Weight in Pounds (KG) 
Substance by generic 100 125 150 185 225 >225 
or chemical name How Supplied (45) (57) (68) (84) (102)
 (>102) 
Medicinal Agents 
Acetaminophen 325mg Tablet III IV IV IV V V 
500mg Tablet II III III IV IV IV 
Acyclovir 200mg Tablet VI VI VI VI VI VI 
400mg Tablet VI VI VI VI VI VI 
800mg Tablet VI VI VI VI VI VI 
Albuterol 2mg Tablet VI VI VI VI VI VI 
4mg Tablet VI VI VI VI VI VI 
12mg/oz Syrup VI VI VI VI VI VI 
Alendronate 5mg Tablet VI VI VI VI VI VI 
10mg Tablet VI VI VI VI VI VI 
40 mg Tablet VI VI VI VI VI VI 
70mg Tablet VI VI VI VI VI VI 
Allopurinol 100mg Tablet VI VI VI VI VI VI 
300mg Tablet V VI VI VI VI VI 
Alprazolam Various V V VI VI VI VI 
Amitriptyline 10mg Tablet V VI VI VI VI VI 
25mg Tablet IV IV IV V V V 
50mg Tablet II III III IV IV IV 
75mg Tablet II II II III III III 
100mg Tablet I II II II II III 
150mg Tablet I I I II II II 
Amlodipine 2.5mg Tablet VI VI VI VI VI VI 
5mg Tablet VI VI VI VI VI VI 
10mg Tablet VI VI VI VI VI VI 
Amoxicillin (Penicillins)     Various    VI     VI       VI         VI         VI      VI 
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Amphetamine Salts* 5mg Tablet II II II III III III 
10mg Tablet I I I II II II 
20mg Tablet I I I I I I 
30mg Tablet I I I I I I 
Aspirin 325mg Tablet IV IV V V VI VI 
650mg Tablet III IV IV IV V V 
25mg Tablet VI VI VI VI VI VI 
Atenolol 50mg Tablet VI VI VI VI VI VI 
100mg Tablet VI VI VI VI VI VI 
250mg Capsule VI VI VI VI VI VI 
Azithromycin 1g Oral Susp. VI VI VI VI VI VI 
100mg Tablet VI VI VI VI VI VI 
Benzonatate 75mg Tablet IV IV IV IV V V 
Bupropion HCL 100mg Tablet III III IV IV IV IV 
150mg Tablet II II III III IV IV 
5mg Tablet VI VI VI VI VI VI 
Buspirone 10mg Tablet VI VI VI VI VI VI 
15mg Tablet VI VI VI VI VI VI 
Caffeine Anacin (32mg) VI VI VI VI VI VI 
Excedrin (64mg) VI VI VI VI VI VI 
NoDoz (100mg) V V VI VI VI VI 
Vivarin (200mg) IV IV IV V V V 
Captopril (ACE inhibitors) 12.5mg Tablet VI VI VI VI VI VI 
25mg Tablet VI VI VI VI VI VI 
50mg Tablet VI VI VI VI VI VI 
Carbamazepine 100mg Tablet IV IV V V V VI 
200mg Tablet III IV IV V V V 
Carisoprodol 350mg Tablet III IV IV IV V V 
Celecoxib 100mg Tablet VI VI VI VI VI VI 
200mg Tablet V V VI VI VI VI 
Cephalexin (cephalosporins) Various VI VI VI VI VI VI 
Cetirizine 5mg Tablet VI VI VI VI VI VI 
10mg Tablet VI VI VI VI VI VI 
Chlorpheniramine 4mg Tablet V V VI VI VI VI 
8mg Tablet V V V V V VI 
12mg Tablet IV IV IV IV V V 
Cimetidine (H2 antagonists) 100mg Tablet VI VI VI VI VI VI 
200mg Tablet VI VI VI VI VI VI 
300mg Tablet VI VI VI VI VI VI 
400mg Tablet VI VI VI VI VI VI 
800mg Tablet VI VI VI VI VI VI 
300mg/5ml syp V (65 oz) V (82 oz) V (98 oz) VI VI VI 
Ciprofloxacin 250mg Tablet VI VI VI VI VI VI 
(flouroquinolones) 500mg Tablet VI VI VI VI VI VI 
750mg Tablet VI VI VI VI VI VI 
Citalopram 20mg Tablet VI VI VI VI VI VI 
40mg Tablet V V V VI VI VI 
10mg/5mL soln IV IV V V VI VI 
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Clarithromycin 250mg Tablet VI VI VI VI VI VI 
500mg Tablet VI VI VI VI VI VI 
125mg/15mL V V VI VI VI VI 
250mg/5mL IV IV IV V V V 
Clindamycin 75mg Capsule VI VI VI VI VI VI 
150mg Capsule VI VI VI VI VI VI 
300mg Capsule V VI VI VI VI VI 
Clonidine 0.1mg Tablet IV IV V V V V 
0.2mg Tablet III III III IV IV IV 
0.3mg Tablet III III III III IV IV 
Clozapine 25mg Tablet V V VI VI VI VI 
100mg Tablet III IV IV IV V V 
Colchicine 0.5mg Tablet I II II II II III 
1.0mg Tablet I I II II II II 
Cocaine* 200mg Dose I I I I II II 
Cyclobenzaprine 10mg Tablet VI VI VI VI VI VI 
Dextromethorphan 10mg/5mL syp II II III III III III 
15mg/5mL syp II II II II III III 
10mg Tablet IV IV V V V V 
30mg Tablet III III III IV IV IV 
15mg Capsule III IV IV IV V V 
Diazepam (and other Various V VI VI VI VI VI 
benzodiazepins) 
Diclofenac 25mg Tablet VI VI VI VI VI VI 
50mg Tablet IV V V V VI VI 
75mg Tablet IV IV IV V V V 
Digoxin 0.125mg Tablet V VI VI VI VI VI 
0.25mg Tablet IV V V VI VI VI 
0.5mg Tablet VI VI VI VI VI VI 
Diltiazem 60mg Tablet IV V V VI VI VI 
90mg Tablet IV IV IV V V V 
120mg Tablet III IV IV IV V V 
180mg Tablet II III III IV IV IV 
240mg Tablet II II III III IV IV 
300mg Tablet II II II III III III 
Diphenhydramine 25mg Tab/Caps IV IV V V V V 
50mg Tab/Caps III III IV IV IV IV 
12.5mg/5mL II II III III III IV 
Doxazosin 1mg Tablet VI VI VI VI VI VI 
2mg Tablet V V VI VI VI VI 
4mg Tablet IV V V V V V 
8mg Tablet IV IV V V V V 
Doxepin 10mg Capsule VI VI VI VI VI VI 
25mg Capsule V VI VI VI VI VI 
50mg Capsule III IV V V VI F 
75mg Capsule III III IV IV V V 
100mg Capsule III III III III IV IV 
150mg Capsule II II III III IV IV 
Doxycycline 50mg Tab/Caps VI VI VI VI VI VI 
100mg Tab/Caps VI VI VI VI VI VI 
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25mg/5mL syp VI VI VI VI VI VI 
50mg/5mL syp VI VI VI VI VI VI 
Ephedrine 25mg Tablet II III III III III III 
50mg Tablet II II II III III III 
Erythromycin 250mg Tablet VI VI VI VI VI VI 
333mg Tablet VI VI VI VI VI VI 
400mg Tablet VI VI VI VI VI VI 
500mg Tablet V VI VI VI VI VI 
Estrogens/Birth control Tablets VI VI VI VI VI VI 
Felodipine 5mg Tablet VI VI VI VI VI VI 
10mg Tablet VI VI VI VI VI VI 
Fexofenadine 60mg Tablet VI VI VI VI VI VI 
Fluconazole 50mg Tablet VI VI VI VI VI VI 
100mg Tablet VI VI VI VI VI VI 
200mg Tablet V VI VI VI VI VI 
Flunitrazepam Various V V V VI VI VI 
Fluoxetine 10mg Tablet VI VI VI VI VI VI 
20mg Tablet V V V V VI VI 
Fluvastatin 20mg Tablet VI VI VI VI VI VI 
40mg Tablet VI VI VI VI VI VI 
Folic Acid 0.1mg Tablet VI VI VI VI VI VI 
0.4mg Tablet VI VI VI VI VI VI 
0.8mg Tablet VI VI VI VI VI VI 
1mg Tablet VI VI VI VI VI VI 
Fosinopril 10mg Tablet VI VI VI VI VI VI 
20mg Tablet VI VI VI VI VI VI 
Furosemide 20mg Tablet VI VI VI VI VI VI 
40mg Tablet VI VI VI VI VI VI 
80mg Tablet VI VI VI VI VI VI 
Gabapentin* ** 100mg Capsule VI VI VI VI VI VI 
300mg Capsule VI VI VI VI VI VI 
400mg Capsule VI VI VI VI VI VI 
Gemfibrozil 300mg Capsule VI VI VI VI VI VI 
600mg Tablet VI VI VI VI VI VI 
GHB* 30mg Dose V V VI VI VI VI 
Glimepiride 1mg Tablet III III III III III III 
2mg Tablet II III III III III III 
4mg Tablet II II III III III III 
Glipizide 5mg Tablet II III III III III III 
10mg Tablet II II III III III III 
Glyburide 1.25mg Tab II III III III III III 
2.5mg Tablet II II III III III III 
5mg Tablet II II II III III III 
Hydrochlorothiazide 25mg Tablet VI VI VI VI VI VI 
50mg Tablet VI VI VI VI VI VI 
100mg Tablet VI VI VI VI VI VI 
Hydroxyzine 10mg Tablet VI VI VI VI VI VI 
25mg Tablet V V V VI VI VI 
50mg Tablet V V V V V V 
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100mg Tablet IV IV IV IV IV IV 
10mg/5mL syp V V V V V V 
Hyoscyamine 0.125mg Tab VI VI VI VI VI VI 
0.15mg Tablet VI VI VI VI VI VI 
0.375mg Tab V V V V VI VI 
Ibuprofen 200mg Tablet V V VI VI VI VI 
300mg Tablet IV V V V VI VI 
400mg Tablet IV IV IV V V V 
600mg Tablet III IV IV IV IV V 
800mg Tablet III III III IV IV IV 
Iron (elemental) 65mg Tablet V V V V VI VI 
Isosorbide Mononitrate 10mg Tablet V VI VI VI VI VI 
S.A. 20mg Tablet IV IV V V V VI 
30mg Tablet III IV IV IV V V 
60mg Tablet III III III III IV IV 
120mg Tablet II II II II II II 
Levothyroxine 0.025mg Tablet VI VI VI VI VI VI 
0.05mg Tablet VI VI VI VI VI VI 
0.1mg Tablet VI VI VI VI VI VI 
0.15mg Tablet VI VI VI VI VI VI 
0.2mg Tablet VI VI VI VI VI VI 
0.3mg Tablet VI VI VI VI VI VI 
0.5mg Tablet V V VI VI VI VI 
Lithium 300mg caps/tab III III III IV IV IV 
450mg Capsule III III III III IV IV 
Loratadine 10mg Tablet VI VI VI VI VI VI 
Lorazepam 0.5mg Tablet VI VI VI VI VI VI 
1mg Tablet VI VI VI VI VI VI 
2mg Tablet VI VI VI VI VI VI 
2mg/mL soln. VI VI VI VI VI VI 
Losartan (Angiotensin II 25mg Tablet VI VI VI VI VI VI 
blockers) 50mg Tablet VI VI VI VI VI VI 
Lovastatin (HMG-CoA 10mg Tablet VI VI VI VI VI VI 
inhibitors) 20mg Tablet VI VI VI VI VI VI 
40mg Tablet VI VI VI VI VI VI 
LSD 0.6mg Blotter VI VI VI VI VI VI 
MDMA-Ecstacy ,100mg dose I I II II II II 
Meclizine 12.5mg Tablet IV V V V V V 
25mg Tab/Caps IV IV IV IV IV IV 
50mg Tablet III III IV IV IV IV 
100mg Tablet III III III III III IV 
50mg/5mL syp II II II II III III 
Metformin 500mg Tablet V V VI VI VI VI 
850mg Tablet V V V V VI VI 
Methadone* 5mg Tablet III III III III III III 
100mg Tablet I I I I I I 
5mg/5mL soln. II II II II II II 
Methocarbamol** 500mg Tablet V V V V V V 
750mg Tablet V V V V V V 
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Methylphenidate 5mg Tablet IV IV V V V V 
10mg Tablet III III IV IV IV IV 
20mg Tablet II II II III III III 
Methylprednisolone 4mg Tablet VI VI VI VI VI VI 
10mg Tablet VI VI VI VI VI VI 
5mg/5mL syp VI VI VI VI VI VI 
Metoprolol 50mg Tablet VI VI VI VI VI VI 
100mg Tablet VI VI VI VI VI VI 
Metronidazole 250mg Tablet IV IV IV V V V 
500mg Tablet II III III IV IV IV 
Minocycline 50mg Tablet VI VI VI VI VI VI 
100mg Tablet VI VI VI VI VI VI 
50mg/5mL susp VI VI VI VI VI VI 
Mirtazapine 15mg Tablet VI VI VI VI VI VI 
30mg Tablet VI VI VI VI VI VI 
Montelukast 5mg Tablet VI VI VI VI VI VI 
10mg Tablet VI VI VI VI VI VI 
Multivitamins (no Iron) Tablets VI VI VI VI VI VI 
Nabumetone 500mg Tablet IV IV IV IV V V 
750mg Tablet III III IV IV IV IV 
Naproxen 200mg Tablet VI VI VI VI VI VI 
250mg Tablet V VI VI VI VI VI 
375mg Tablet V V V VI VI VI 
500mg Tablet IV IV V V VI VI 
Nefazodone 100mg Tablet V V V VI VI VI 
150mg Tablet IV V V V V V 
200mg Tablet IV IV V V V V 
250mg Tablet IV IV IV IV IV IV 
Nifedipine 10mg Capsule III III IV IV IV IV 
20mg Capsule II III III III III IV 
30mg SR Tablet II II III III III III 
60mg SR Tablet II II II III III III 
90mg SR Tablet I II II II II II 
Nitrofurantoin 50mg Capsule V VI VI VI VI VI 
100mg Capsule IV IV V V VI VI 
25mg/5mL susp IV IV IV IV V V 
Nitroglycerin 0.3mg sublingual VI VI VI VI VI VI 
0.4mg subling VI VI VI VI VI VI 
0.6mg subling VI VI VI VI VI VI 
2.5mg Capsule VI VI VI VI VI VI 
6.5mg Capsule VI VI VI VI VI VI 
9mg Capsule VI VI VI VI VI VI 
13mg Capsule VI VI VI VI VI VI 
Nortriptyline 10mg Capsule V V VI VI VI VI 
25mg Capsule IV IV IV V V V 
50mg Capsule II III III IV IV IV 
75mg Capsule I II II III III III 
Olanzapine 5mg Tablet V V V V V V 
7.5mg Tablet V V V V V V 
10mg Tablet IV IV V V V V 
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Omeprazole (proton pump 20mg capsule VI VI VI VI VI VI 
inhibitors) 
Oxycodone* ** 5mg Tablet II III III III III III 
10mg Tablet II II II III III III 
20mg Tablet II II II II II II 
40mg Tablet I II II II II II 
80mg Tablet I I I II II II 
Paroxetine 10mg Tablet VI VI VI VI VI VI 
20mg Tablet V VI VI VI VI VI 
30mg Tablet V V V V V V 
40mg Tablet V V V V V V 
Phenazopyridine 100mg Tablet V V V V V V 
200mg Tablet V V V V V V 
Phenelzine 15mg Tablet I II II II II III 
Phenobarbital* ** 8mg Tablet V V V V V V 
16mg tab/caps III IV IV IV V V 
32mg Tablet II II II III III III 
65mg Tablet I I I II II II 
100mg Tablet I I I I I I 
Phenytoin 30mg Capsule VI VI VI VI VI VI 
50mg Tablet VI VI VI VI VI VI 
100mg Capsule V V VI VI VI VI 
30mg/5mL syp IV IV IV V V V 
Pioglitazone 15mg Tablet V V V V V V 
30mg Tablet IV IV IV IV IV IV 
45mg Tablet IV IV IV IV IV IV 
Potassium Chloride 8mEq Capsule III III IV IV IV IV 
10mEq Capsule II III III IV IV IV 
Promethazine 12.5mg Tablet VI VI VI VI VI VI 
25mg Tablet VI VI VI VI VI VI 
50mg Tablet IV V V V VI VI 
25mg/5mL syp II III III IV IV IV 
Propoxyphene** 65mg II II III III III IV 
Propranolol 10mg Tablet V V V V V V 
20mg Tablet IV V V V V V 
40mg Tablet III IV IV IV IV V 
60mg Tablet II III III IV IV IV 
80mg Tablet II II II III III D 
90mg Tablet II II II III III III 
120mg Capsule I II II II II III 
160mg Capsule I I II II II II 
Pseudoephedrine 60mg Tablet IV IV IV IV IV IV 
120mg Capsule III III III III III IV 
240mg Capsule II II II II II III 
30mg/5mL syp II II II II III III 
Quetiapine 25mg Tablet VI VI VI VI VI VI 
100mg Tablet V V V VI VI VI 
200mg Tablet IV IV IV IV V V 
Quinine 200mg Capsule II III III IV IV IV 
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260mg Tab/Caps II II II III III IV 
325mg Capsule II II II II III III 
Risperidone 0.25mg Tablet V VI VI VI VI VI 
0.5mg Tablet V V VI VI VI VI 
1mg Tablet V V V VI VI VI 
2mg Tablet V V V V VI VI 
3mg Tablet V V V V V VI 
4mg Tablet IV IV V V V V 
Salmeterol 100mg Tablet VI VI VI VI VI VI 
Sildenafil Citrate 25mg Tablet VI VI VI VI VI VI 
50mg Tablet V V V V V V 
100mg Tablet V V V V V V 
Spironolactone 25mg Tablet VI VI VI VI VI VI 
50mg Tablet VI VI VI VI VI VI 
100mg Tablet VI VI VI VI VI VI 
Sumatriptan 25mg Tablet IV IV IV V V V 
50mg Tablet V V V V V V 
Tamoxifen 10mg Tablet V V V V V V 
20mg Tablet V V V V V V 
Terazosin (alpha 1 1mg Tab/Caps VI VI VI VI VI VI 
Blockers) 2mg Tab/Caps VI VI VI VI VI VI 
5mg Tab/Caps V V VI VI VI VI 
10mg Tab/Caps V V V V VI VI 
Theophylline 100mg Tab/Caps I I II II II II 
200mg Tab/Caps I I I I I I 
250mg Tablet I I I I I I 
300mg Tablet I I I I I I 
Tolterodine 1mg Tablet VI VI VI VI VI VI 
2mg Tablet VI VI VI VI VI VI 
Tramadol 50mg Tablet II III III IV IV IV 
Trazodone 50mg Tablet VI VI VI VI VI VI 
100mg Tablet VI VI VI VI VI VI 
150mg Tablet VI VI VI VI VI VI 
300mg Tablet V V VI VI VI VI 
Triazolam Various V V VI VI VI VI 
Triamterene/HCTZ Various V V V V V V 
Trimeth/Sulfameth Various V V V V V V 
Valproic Acid 250mg Tab/Caps V V VI VI VI VI 
500mg Tablet IV IV V V V V 
Venlafaxine 25mg Tablet V V V VI VI VI 
37.5mg Tablet V V V V V V 
50mg Tablet V V V V V V 
75mg Tablet IV IV V V V V 
100mg Tablet IV IV IV IV IV IV 
Verapamil 40mg Tablet IV IV IV IV IV IV 
80mg Tablet IV IV IV IV V V 
120mg Tablet III III IV IV IV IV 
180mg Caplet II III III III IV IV 
240mg Caplet II II II III III III 
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Warfarin 1mg Tablet VI VI VI VI VI VI 
2mg Tablet V V VI VI VI VI 
2.5mg Tablet V V V V V V 
5mg Tablet IV V V VI VI V 
7.5mg Tablet IV IV IV IV V V 
10mg Tablet III III III IV IV IV 
Zolpidem 5mg Tablet VI VI VI VI VI VI 
10mg Tablet VI VI VI VI VI VI 
*Patients with a history of abuse/chronic use will be able to tolerate higher doses 
**Co-ingestion of ethanol increases toxicity significantly 
 
Nonmedicinal chemicals 
Acids (pH < 2) Liquid/solid I I I I I I 
Alkalines (pH > 12) Liquid/solid I I I I I I 
Arsenic (organic and inorganic) Liquid/solid I/II I/II I/II I/II I/II I/II 
Bleach (hypochlorite) Liquid IV IV IV V V V 
Cosmetics Liquid/solid VI VI VI VI VI VI 
Cyanide Liquid/solid I I I I I I 
Ethylene glycol Liquid I I I I I I 
Fertilizers Liquid/solid VI VI VI VI VI VI 
Gasoline Liquid III III III III III IV 
Herbicide, Chlorphenoxy Liquid/solid IV/III IV/III IV/III IV/III IV/III
 IV/III 
Herbicide, Paraquat Liquid I I I I I I 
Hydrofluoric acid (>5%) Liquid I I I I I I 
Insecticides, Carbamates Liquid/solid I I I I I I 
Insecticides, Organophosphate Liquid/solid I I I I I I 
Insecticides, Pyrethrins Liquid/solid IV IV IV IV V V 
Mercury (elemental) Liquid III III III III IV/III
 IV/III 
Mercury, Chloride (inorganic) Liquid/solid I I I I I II 
Mercury, Methyl (organic) Liquid/solid I I I I II I 
Methanol Liquid I I I I I I 
Mushroom, Aminita Sp. Solid I/II I/II I/II I/II I/II I/II 
Mushroom, Psilocybin Solid V V V V V V 
Mushroom, Other Solid III/IV III/IV III/IV III/IV III/IV
 III/IV 
Rat poison (brodifacoum) Solid Pellets II II II II II III 
Silica Gel Solid VI VI VI VI VI VI 
Solvents Liquid II-IV II-IV II-IV II-IV II-IV II-
IV 
Strychnine Liquid/solid I I I I I I 
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Data Entry Form 
 
Variable Value Level of Measurement 
Case ID  nominal (#001 to #362) 
Demographic variables:   
Gender – Male, Female  nominal (Male=1, 
Female=0) 
Race – Caucasian/White, African-
American/Black, Hispanic/Latino, Asian, 
Other 
 nominal 
(Caucasian/White=1, 
African-
American/Black=2, 
Hispanic/Latino=3, 
Asian=4, Biracial=5, 
Other=6) 
Age – 13 years to 18 years  interval (13-18) 
Age Group – Younger (13-15), Older (16-
18) 
 nominal (Younger=1, 
Older=0) 
Psychopathology variables:   
Depressive Disorder  dichotomous (Y=1, N=0) 
Bipolar Disorder  dichotomous (Y=1, N=0) 
Mood Disorder NOS  dichotomous (Y=1, N=0) 
Disruptive Disorder  dichotomous (Y=1, N=0) 
Substance Abuse Disorder  dichotomous (Y=1, N=0) 
Anxiety Disorder  dichotomous (Y=1, N=0) 
Other Disorder  dichotomous (Y=1, N=0) 
Diagnostic History variables:   
Disruptive Disorder  dichotomous (Y=1, N=0) 
Substance Abuse Disorder  dichotomous (Y=1, N=0) 
Method variable:   
Suicide Attempt Method Used  nominal 
(ingestion/poisoning=1, 
cutting=2, suffocation=3, 
strangulation=4, 
jumping=5, hanging=6, 
firearm=7, swallowing of 
object=8, electrocution=9, 
drowning=10) 
Lethality variable:   
LSARS-II Score  ratio (0.0-10.0) 
 
 
